Charles Nemeroff
#15,221
Most Influential Person Now
American psychiatrist
Charles Nemeroff's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Charles Nemeroff Influential?
(Suggest an Edit or Addition)According to Wikipedia, Charles Barnet Nemeroff is an American psychiatrist known for his works about depression. He is the author of numerous textbooks, papers, and clinical studies. Early life and education Nemeroff was born in New York City and attended the City College of New York. During his freshman year at the college, he visited Manhattan State Hospital where he decided to pursue his career studying mental illness. He also participated in an undergraduate research program sponsored by the National Science Foundation. Nemeroff went to work as a technician in a neuropathology laboratory in Boston after graduating in 1970. He subsequently returned to school where he received a master's degree in Biology in 1973 from Northeastern University. He then earned his PhD in neurobiology in 1973 and his M.D. in 1981, both from the University of North Carolina at Chapel Hill.
Charles Nemeroff's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Papers
- The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies (2001) (2598)
- Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. (2000) (1607)
- The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. (1998) (1605)
- Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. (1984) (1484)
- The link between childhood trauma and depression: Insights from HPA axis studies in humans (2008) (1449)
- The role of corticotropin-releasing factor in depression and anxiety disorders. (1999) (1331)
- A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. (2000) (1290)
- Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. (2008) (1246)
- Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions (2012) (1178)
- Physiology and pharmacology of corticotropin-releasing factor. (1991) (1151)
- The role of dopamine in the pathophysiology of depression. (2007) (1088)
- Paroxetine for the prevention of depression induced by high-dose interferon alfa. (2001) (1061)
- Mood Disorders in the Medically Ill: Scientific Review and Recommendations (2005) (1009)
- Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders (2000) (940)
- Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. (1994) (902)
- Early Life Programming and Neurodevelopmental Disorders (2010) (826)
- The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. (2005) (815)
- Childhood trauma associated with smaller hippocampal volume in women with major depression. (2002) (789)
- Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma (2003) (740)
- Long-term behavioral and neuroendocrine adaptations to adverse early experience. (2000) (733)
- Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions (2002) (714)
- Depression, desperation, and suicidal ideation in college students: results from the American Foundation for Suicide Prevention College Screening Project at Emory University (2008) (704)
- Neuropsychopharmacology : The Fifth Generation of Progress (2002) (703)
- Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. (1997) (690)
- Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. (1998) (649)
- Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. (1997) (645)
- Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. (1996) (644)
- Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. (2008) (643)
- Posttraumatic stress disorder: a state-of-the-science review. (2006) (643)
- Are mood disorders and obesity related? A review for the mental health professional. (2004) (633)
- Neurobiological and psychiatric consequences of child abuse and neglect. (2010) (566)
- The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. (1996) (556)
- Exaggerated platelet reactivity in major depression. (1996) (552)
- Neurobiological consequences of childhood trauma. (2004) (551)
- Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. (1988) (547)
- Depression in patients with cancer. Diagnosis, biology, and treatment. (1995) (544)
- Epidemiology of comorbid coronary artery disease and depression (2003) (538)
- CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. (1994) (535)
- Importance of Studying the Contributions of Early Adverse Experience to Neurobiological Findings in Depression (2004) (522)
- Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. (1996) (520)
- Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety (2009) (518)
- Effects of early adverse experiences on brain structure and function: clinical implications (2000) (514)
- Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography (1998) (512)
- Paradise Lost: The Neurobiological and Clinical Consequences of Child Abuse and Neglect (2016) (512)
- Post-traumatic stress disorder: the neurobiological impact of psychological trauma (2011) (500)
- The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders (1999) (496)
- Long-Term Consequences of Neonatal Rearing on Central Corticotropin-Releasing Factor Systems in Adult Male Rat Offspring (2005) (491)
- Interferon-alpha–induced changes in tryptophan metabolism relationship to depression and paroxetine treatment (2003) (474)
- Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress (1986) (473)
- Lower CSF oxytocin concentrations in women with a history of childhood abuse (2009) (473)
- Altered Pituitary-Adrenal Axis Responses to Provocative Challenge Tests in Adult Survivors of Childhood Abuse (2001) (469)
- Newer antidepressants and the cytochrome P450 system. (1996) (467)
- Interoception and Mental Health: A Roadmap (2017) (464)
- The Bidirectional Relationship of Depression and Inflammation: Double Trouble (2020) (457)
- The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: A multiple regression analysis (2002) (450)
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression. (2015) (449)
- Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. (2002) (448)
- The neurobiology of depression: inroads to treatment and new drug discovery. (2005) (440)
- Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. (2006) (435)
- Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. (2001) (430)
- Long-Term Behavioral Effects of Repetitive Pain in Neonatal Rat Pups (1999) (425)
- Neurobiology of posttraumatic stress disorder (2000) (400)
- Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus (1990) (398)
- Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine (2001) (392)
- Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mrna and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation (2004) (365)
- Prevalence and management of treatment-resistant depression. (2007) (364)
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders (2017) (356)
- Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. (2001) (355)
- Heartache and heartbreak—the link between depression and cardiovascular disease (2012) (346)
- Platelet/Endothelial Biomarkers in Depressed Patients Treated With the Selective Serotonin Reuptake Inhibitor Sertraline After Acute Coronary Events: The Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy (2003) (344)
- The Dexamethasone/Corticotropin-Releasing Factor Test in Men with Major Depression: Role of Childhood Trauma (2008) (341)
- Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. (1992) (339)
- CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. (1987) (336)
- Increased Stress-Induced Inflammatory Responses in Male Patients With Major Depression and Increased Early Life Stress (2006) (333)
- Long‐term behavioural and molecular alterations associated with maternal separation in rats (2007) (332)
- Hypercortisolemia and depression. (2005) (331)
- The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. (2009) (331)
- The CRF system, stress, depression and anxiety—insights from human genetic studies (2010) (322)
- Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. (2003) (319)
- Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. (2005) (302)
- VNS Therapy in Treatment-Resistant Depression: Clinical Evidence and Putative Neurobiological Mechanisms (2006) (302)
- Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. (1997) (298)
- Role of norepinephrine in the pathophysiology and treatment of mood disorders (1999) (296)
- Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. (2003) (295)
- Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling (2015) (293)
- The effects of child abuse and neglect on cognitive functioning in adulthood. (2012) (293)
- Treatment of mood disorders (2002) (293)
- The burden of severe depression: a review of diagnostic challenges and treatment alternatives. (2007) (286)
- Neurobiology of early life stress: clinical studies. (2002) (284)
- Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin (1976) (284)
- Neurotensin: perchance an endogenous neuroleptic? (1980) (279)
- Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healthy volunteers. (1994) (271)
- Hypercortisolemia and hippocampal changes in depression (1993) (269)
- Neurotensin: Central nervous system effects of a hypothalamic peptide (1977) (264)
- Women at risk for postpartum-onset major depression. (1995) (262)
- Adrenal gland enlargement in major depression. A computed tomographic study. (1992) (261)
- Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal (2011) (260)
- A magnetic resonance imaging study of putamen nuclei in major depression (1991) (259)
- Parental depression: animal models of an adverse life event. (2002) (256)
- Neurotensin and dopamine interactions. (2001) (249)
- Neuropeptide Concentrations in the Cerebrospinal Fluid of Depressed Patients Treated with Electroconvulsive Therapy (1991) (248)
- The role of GABA in the pathophysiology and treatment of anxiety disorders. (2003) (243)
- The neurobiology of depression. (1998) (243)
- Effect of Childhood Trauma on Adult Depression and Neuroendocrine Function: Sex-Specific Moderation by CRH Receptor 1 Gene (2009) (242)
- Clinical Pharmacokinetics of Quetiapine (2001) (238)
- Depression during pregnancy and the puerperium. (1997) (237)
- The Neurobiological Toll of Child Abuse and Neglect (2009) (237)
- The corticotropin-releasing hormone test in patients with posttraumatic stress disorder (1989) (233)
- Etiology of depression: genetic and environmental factors. (2012) (232)
- Divalproex in the Treatment of Impulsive Aggression: Efficacy in Cluster B Personality Disorders* (2003) (228)
- Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia. (1983) (223)
- Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. (2000) (220)
- Anterior Cingulate Activation and Error Processing During Interferon-Alpha Treatment (2005) (216)
- Personalized medicine in psychiatry: problems and promises (2013) (215)
- Leukoencephalopathy in patients diagnosed as major depressive (1988) (214)
- Neurotensin blocks certain amphetamine-induced behaviours (1981) (214)
- Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat (1983) (214)
- Does psychosocial functioning improve independent of depressive symptoms? a comparison of nefazodone, psychotherapy, and their combination (2002) (214)
- Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder. (2017) (212)
- Pituitary size in depression. (1991) (211)
- Persistent changes in corticotropin-releasing factor systems due to early life stress: relationship to the pathophysiology of major depression and post-traumatic stress disorder. (1997) (211)
- Decreased cortical representation of genital somatosensory field after childhood sexual abuse. (2013) (210)
- Cerebrospinal fluid concentrations of corticotropin‐releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: Response to amitriptyline treatment (1998) (209)
- Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium L-glutamate (MSG): evidence for the involvement of tuberoinfundibular cholinergic and dopaminergic systems in neuroendocrine regulation. (1977) (206)
- Elevated CSF CRF in suicide victims (1989) (202)
- Subcortical hyperintensities on brain magnetic resonance imaging: A comparison between late age onset and early onset elderly depressed subjects (1991) (201)
- Differential functional connectivity within an emotion regulation neural network among individuals resilient and susceptible to the depressogenic effects of early life stress (2012) (201)
- Neurobiological effects of childhood abuse: implications for the pathophysiology of depression and anxiety (2003) (200)
- Psychedelics and Psychedelic-Assisted Psychotherapy. (2020) (197)
- Are platelets the link between depression and ischemic heart disease? (2000) (196)
- The Role of Early Adverse Life Events in the Etiology of Depression and Posttraumatic Stress Disorder (1997) (196)
- The effects of neonatal stress on brain development: Implications for psychopathology (1999) (195)
- The role of corticotropin-releasing factor in the pathogenesis of major depression. (1988) (191)
- Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy (2007) (187)
- The relationship of depression and diabetes: Pathophysiological and treatment implications (2011) (187)
- Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse (2004) (186)
- Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies. (1983) (186)
- Effects of Interferon-Alpha on Rhesus Monkeys: A Nonhuman Primate Model of Cytokine-Induced Depression (2007) (185)
- Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs (2008) (182)
- Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. (2002) (181)
- Assessment and treatment of depression in the cancer patient. (1998) (180)
- Cerebrospinal Fluid Corticotropin-Releasing Factor and Perceived Early-Life Stress in Depressed Patients and Healthy Control Subjects (2004) (176)
- Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine. (1979) (175)
- Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. (2007) (175)
- Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression (2016) (175)
- Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing (2005) (173)
- Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. (2007) (173)
- The Devastating Clinical Consequences of Child Abuse and Neglect: Increased Disease Vulnerability and Poor Treatment Response in Mood Disorders. (2019) (171)
- The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. (1993) (170)
- Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing (1984) (168)
- Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity (2003) (163)
- The interaction of neurotensin with dopaminergic pathways in the central nervous system: Basic neurobiology and implications for the pathogenesis and treatment of schizophrenia (1986) (163)
- Genome-wide DNA methylation levels and altered cortisol stress reactivity following childhood trauma in humans (2016) (163)
- International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol (2011) (160)
- Maintenance Efficacy of Divalproex in the Prevention of Bipolar Depression (2003) (160)
- Dosing the antipsychotic medication olanzapine. (1997) (160)
- The Links Between Stress and Depression: Psychoneuroendocrinological, Genetic, and Environmental Interactions. (2016) (159)
- Neurochemical alterations of serotonergic neuronal systems in depression. (1992) (158)
- Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations. (1985) (156)
- Sertraline and desmethylsertraline in human breast milk and nursing infants. (1997) (155)
- Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety. (2004) (155)
- Depression and anxiety: Role of the locus coeruleus and corticotropin-releasing factor (1994) (154)
- Depression and Endocrine Disorders: Focus on the Thyroid and Adrenal System (1996) (154)
- Recent advances in the neurobiology of depression. (2002) (152)
- CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse (1992) (150)
- Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions. (1998) (149)
- Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing. (2002) (147)
- Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment. (1982) (147)
- The American Psychiatric Press Textbook of Psychopharmacology (1995) (146)
- Depression and cardiac disease (1998) (145)
- The American Psychiatric Publishing Textbook of Psychopharmacology (2009) (145)
- The neurobiology of urocortin (2000) (144)
- Placebo-controlled study of fluvoxamine in the treatment of patients with compulsive buying. (2000) (141)
- An Interactive Web-Based Method of Outreach to College Students at Risk for Suicide (2008) (141)
- Polymorphisms in CRHR1 and the Serotonin Transporter Loci: Gene × Gene × Environment Interactions on Depressive Symptoms (2009) (140)
- Neurobiology of early life stress: rodent studies. (2002) (138)
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. (2021) (137)
- Paroxetine in human breast milk and nursing infants. (2000) (136)
- Antithyroid antibodies in depressed patients. (1985) (133)
- Self-Reported Depressive Symptom Measures: Sensitivity to Detecting Change in a Randomized, Controlled Trial of Chronically Depressed, Nonpsychotic Outpatients (2005) (132)
- Maternal separation in neonatal rats elicits activation of the hypothalamic-pituitary-adrenocortical axis: A putative role for corticotropin-releasing factor (1993) (131)
- Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. (1991) (131)
- Depressive symptoms and viral clearance in patients receiving interferon-α and ribavirin for hepatitis C (2005) (130)
- Neurotensin-induced hypothermia: Evidence for an interaction with dopaminergic systems and the hypothalamic-pituitary-thyroids axis (1980) (130)
- In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: Relationship to dexamethasone suppression test results in patients (1992) (129)
- Variable foraging demand rearing: sustained elevations in cisternal cerebrospinal fluid corticotropin-releasing factor concentrations in adult primates (2001) (129)
- Neurotensin-dopamine interactions in the CNS (1985) (129)
- Contemporary management of depression. (1994) (128)
- Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale (2005) (127)
- New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor. (1992) (127)
- The effect of neurotensin on food consumption in the rat. (1982) (127)
- The Neural Correlates of Social Anxiety Disorder and Response to Pharmacotherapy (2006) (125)
- The biology of depression in cancer and the relationship between depression and cancer progression (2014) (125)
- Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. (2002) (123)
- Subclinical Hypothyroidism: A Review of Neuropsychiatric Aspects (1990) (122)
- Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus (2012) (122)
- Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes (2009) (122)
- Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. (1989) (119)
- Pharmacology of valproate. (2003) (119)
- Persistent central nervous system effects of an adverse early environment: clinical and preclinical studies (2003) (119)
- The serotonin transporter and depression (1998) (118)
- Chronic Administration of the Triazolobenzodiazepine Alprazolam Produces Opposite Effects on Corticotropin-Releasing Factor and Urocortin Neuronal Systems (2000) (115)
- Elevation of immunoreactive CSF TRH in depressed patients. (1988) (114)
- Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in children and adolescents. (2003) (114)
- Cholecystokinin inhibits tail pinch-induced eating in rats. (1978) (114)
- Neurotensin: Role in psychiatric and neurological diseases (2006) (114)
- Apolipoprotein E-ε4 frequency in geriatric depression (1996) (114)
- Neurobiology of posttraumatic stress disorder. (2003) (114)
- The neurobiology of neurotensin: focus on neurotensin-dopamine interactions (1991) (113)
- Increase in spontaneous motor activity following infusion of neurotensin into the ventral tegmental area (1981) (112)
- National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. (2002) (112)
- Regional Distribution of Neurotensin in Human Brain (1982) (112)
- Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. (2007) (111)
- Sensitivity to glucocorticoid-mediated fast-feedback regulation of the hypothalamic–pituitary–adrenal axis is dependent upon stressor specific neurocircuitry (2000) (110)
- Functional brain imaging alterations in acne patients treated with isotretinoin. (2005) (109)
- Defective Inflammatory Pathways in Never-Treated Depressed Patients Are Associated with Poor Treatment Response (2018) (109)
- Serotonin Transporter: A Potential Substrate in the Biology of Suicide (2003) (108)
- Growth, endocrinological and behavioral deficits after monosodium l-glutamate in the neonatal rat: possible involvement of arcuate dopamine neuron damage (1977) (108)
- Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression. (2002) (108)
- Depression in women treated for gynecological cancer: clinical and neuroendocrine assessment. (1986) (108)
- Neurotensin: Topographical distribution of brain sites involoved in hypothermia and antinociception (1982) (108)
- The neurobiology of bipolar disorder (2003) (106)
- Differential effects of antipsychotic drugs on the neurotensin concentration of discrete rat brain nuclei. (1988) (106)
- Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. (2010) (105)
- Neurotensin-induced antinociception in mice: antagonism by thyrotropin-releasing hormone. (1981) (104)
- Dr. Nemeroff and Colleagues Reply (1996) (104)
- Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder. (2005) (104)
- CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder. (1997) (104)
- DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions (2013) (103)
- Early Life Stress, Mood, and Anxiety Disorders (2017) (103)
- Increase in dopamine metabolites in rat brain by neurotensin. (1982) (103)
- Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders. (1986) (103)
- Psychopharmacology of affective disorders in the 21st century. (1998) (103)
- Neurokinin(1) receptor antagonists as potential antidepressants. (2001) (103)
- Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients. (1991) (102)
- INTERACTIONS OF NEUROTENSIN WITH BRAIN DOPAMINE SYSTEMS * (1982) (102)
- From Clinical Research to Clinical Practice: A 4-Year Review of Ziprasidone (2005) (102)
- Use of atypical antipsychotics in refractory depression and anxiety. (2005) (101)
- A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression. (2009) (101)
- Comparing the Effects of Antidepressants: Consensus Guidelines for Evaluating Quantitative Reviews of Antidepressant Efficacy (2005) (100)
- The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. (2010) (99)
- Neurotoxic amino acids and structurally related analogs. (1977) (99)
- Further studies on platelet serotonin transporter binding in depression. (1994) (98)
- Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. (1988) (98)
- Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing. (2018) (97)
- The interface of depression and cardiovascular disease: therapeutic implications (2015) (97)
- Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats. (2000) (97)
- Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis. (2019) (96)
- Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. (1990) (94)
- The Corticotropin-Releasing Factor1 Receptor Antagonist R121919 Attenuates the Behavioral and Endocrine Responses to Stress (2003) (94)
- Correlation between the dexamethasone suppression test in depressed patients and clinical response. (1984) (94)
- Neurotensin: central nervous system effects of a neuropeptide (1980) (93)
- The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal. (1991) (93)
- Neurotensin-induced hypothermia in the rat: Structure-activity studies (1978) (93)
- Posterior fossa abnormalities in major depression: a controlled magnetic resonance imaging study (1992) (93)
- Depression as a risk factor for cancer: from pathophysiological advances to treatment implications. (2014) (92)
- The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. (2007) (92)
- The concise Corsini encyclopedia of psychology and behavioral science (2004) (92)
- Developing novel treatments for mood disorders: accelerating discovery (2002) (92)
- Pharmacologic Differences Among the SSRIs: Focus on Monoamine Transporters and the HPA Axis (2004) (91)
- Antinociception after microinjection of neurotensin into the central amygdaloid nucleus of the rat (1982) (91)
- Hyperintense lesions on magnetic resonance images in bipolar disorder (1999) (91)
- Stress, Neuropeptides, and Systemic Disease (1991) (90)
- Sertraline in the treatment of women with postpartum major depression (1995) (90)
- Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. (2001) (90)
- Cortisol concentrations in 12- to 18-Month-Old infants: stability over time, location, and stressor (2003) (90)
- The Biochemical Basis of Neuropharmacology, 8th ed. (2004) (89)
- Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial (2012) (89)
- Prediction of Antidepressant Response to Milnacipran by Norepinephrine Transporter Gene Polymorphisms (2004) (89)
- The dexamethasone suppression test in the clinical setting. (1983) (89)
- Early Life Stress Combined with Serotonin 3A Receptor and Brain-Derived Neurotrophic Factor Valine 66 to Methionine Genotypes Impacts Emotional Brain and Arousal Correlates of Risk for Depression (2010) (89)
- Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study. (2017) (88)
- Neurotensin and Bombesin (1983) (88)
- Cerebrospinal fluid neuropeptides in mood disorder and dementia. (1992) (88)
- Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression. (2006) (88)
- Increased responsiveness of presumed 5-HT cells to citalopram in adult rats subjected to prolonged maternal separation relative to brief separation (2004) (87)
- Safety of available agents used to treat bipolar disorder: focus on weight gain. (2003) (87)
- Elevated cerebrospinal fluid substance P concentrations in posttraumatic stress disorder and major depression (2006) (86)
- Acute effects of alprazolam and adinazolam on the concentrations of corticotropin‐releasing factor in the rat brain (1989) (85)
- In vivo stereological assessment of caudate volume in man: effect of normal aging. (1990) (85)
- A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. (2006) (85)
- Evolutionary trends in the pharmacotherapeutic management of depression. (1994) (85)
- Hippocampal abnormalities in depression. (1991) (84)
- Variation in the oxytocin receptor gene is associated with increased risk for anxiety, stress and depression in individuals with a history of exposure to early life stress. (2014) (83)
- Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine. (2002) (83)
- Neurotensin, a biologically active peptide. (1978) (83)
- The presence of antithyroid antibodies in patients with affective and nonaffective psychiatric disorders (1990) (82)
- The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs (2001) (82)
- The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations. (2003) (82)
- Stress and psychiatric disorders (1994) (81)
- Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation (2006) (80)
- Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients. (1988) (80)
- Lithium, but Not Fluoxetine or the Corticotropin-Releasing Factor Receptor 1 Receptor Antagonist R121919, Increases Cell Proliferation in the Adult Dentate Gyrus (2011) (80)
- Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls (1995) (80)
- Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin. (1982) (79)
- Differing concentrations of corticotropin-releasing factor and oxytocin in the cerebrospinal fluid of bonnet and pigtail macaques (2002) (79)
- Essentials of Clinical Psychopharmacology (2001) (79)
- Venlafaxine: a novel antidepressant that has a dual mechanism of action. (1996) (79)
- Enhanced Neurotensin Neurotransmission Is Involved in the Clinically Relevant Behavioral Effects of Antipsychotic Drugs: Evidence from Animal Models of Sensorimotor Gating (2001) (78)
- Augmentation strategies in patients with refractory depression (1996) (77)
- The effects of thyroid state on beta-adrenergic and serotonergic receptors in rat brain (1987) (76)
- Toward an understanding of decision making in severe mental illness. (2014) (76)
- Effects of Paroxetine and Venlafaxine XR on Heart Rate Variability in Depression (2005) (76)
- Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects (1993) (75)
- Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood (2010) (74)
- Neurochemical correlates of sympathetic activation during severe alcohol withdrawal. (1994) (74)
- New antidepressants and the cytochrome P450 system: Focus on venlafaxine, nefazodone, and mirtazapine (1998) (74)
- Problems with currently available antidepressants. (2000) (74)
- Prevention of stress-induced gastric ulcers by dopamine agonists in the rat. (1984) (74)
- The effect of centrally administered neuropeptides on the development of stress‐induced gastric ulcers in rats (1983) (74)
- Hypothalamic‐Pituitary‐Adrenal Axis and Suicide (1986) (73)
- Does neurotensin mediate the effects of antipsychotic drugs? (1999) (73)
- The Corsini encyclopedia of psychology and behavioral science (2001) (73)
- Treatment of depression in cancer patients is associated with better life adaptation: a pilot study. (1988) (73)
- Cape Town consensus on posttraumatic stress disorder. (2009) (72)
- CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: Its relationship to severity of dementia and monoamine metabolites (1989) (72)
- Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects (1996) (72)
- Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's disease (1985) (71)
- The dexamethasone suppression test in mixed bipolar disorder. (1983) (71)
- Centrally administered neurotensin: activity in the Julou-Courvoisier muscle relaxation test in mice. (1979) (71)
- Release of corticotropin-releasing factor from rat brain regions in vitro. (1986) (71)
- 5a-Pregnane-3a,21-diol-20-one (THDOC) attenuates mild stress-induced increases in plasma corticosterone via a non-glucocorticoid mechanism: comparison with alprazolam (1992) (70)
- TREATMENT OF DEPRESSION IN CARDIOVASCULAR DISEASE (2013) (70)
- Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. (1994) (70)
- Pharmaco-behavioral effects of hypothalamic peptides in animals and man: focus on thyrotropin-releasing hormone and neurotensin (1978) (70)
- Role of Norepinephrine in the Pathophysiology of Neuropsychiatric Disorders (2001) (70)
- Corticotropin releasing factor (CRF): studies in alcohol preferring and non-preferring rats (1992) (69)
- Impulsive Choice and Psychological Pain in Acutely Suicidal Depressed Patients (2014) (69)
- Impact of Physical Illness on Quality of Life and Antidepressant Response in Geriatric Major Depression (1996) (69)
- Models of neuroendocrine regulation: use of monosodium glutamate as an investigational tool. (1978) (69)
- Emerging targets for antidepressant therapies. (2009) (69)
- Drug Repositioning in Glioblastoma: A Pathway Perspective (2018) (69)
- The role of corticotropin-releasing hormone in the pathophysiology of depression: therapeutic implications. (2011) (68)
- The Neurobiology of Neurotensin (1992) (68)
- Hormonal Treatments for Major Depressive Disorder: State of the Art. (2020) (68)
- How Are You? (1999) (68)
- Enhancement of ethanol-induced sedation and hypothermia by centrally administered neurotensin, β-endorphin and bombesin (1981) (67)
- Peptides and the Central Nervous System (1978) (67)
- The revolution of personalized psychiatry: will technology make it happen sooner? (2017) (67)
- A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients. (2007) (66)
- Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot study (2005) (66)
- Neurobiology of Early-Life Stress (2003) (66)
- Pharmacotherapy of depression and mixed states in bipolar disorder. (2000) (66)
- Modification of pentobarbital effects by natural and synthetic polypeptides: dissociation of brain and pituitary effects. (1975) (65)
- Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. (1993) (65)
- Decreased activity in right-hemisphere structures involved in social cognition in siblings discordant for schizophrenia (2012) (65)
- A validated predictive algorithm of post-traumatic stress course following emergency department admission after a traumatic stressor (2020) (65)
- CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression (1988) (65)
- Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. (2010) (65)
- Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder (2017) (65)
- Marked reduction in gonadal steroid hormone levels in rats treated neonatally with monosodium L-glutamate: further evidence for disruption of hypothalamic-pituitary-gonadal axis regulation. (1981) (65)
- Repeated neurotensin administration in the ventral tegmental area: Effects on baseline and d-amphetamine-induced locomotor activity (1986) (64)
- Anxiolytics: past, present, and future agents. (2003) (64)
- Reduced CSF neurotensin concentration in drug-free schizophrenic patients (1988) (64)
- Elevated plasma concentrations of alpha 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients. (1990) (63)
- Cerebrospinal Fluid Concentrations of Corticotropin-Releasing Hormone (CRH) and Diazepam-Binding Inhibitor (DBI) during Alcohol Withdrawal and Abstinence (1996) (63)
- The mesocorticolimbic dopamine system. (1988) (63)
- Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain. (1990) (63)
- Altered Pituitary Hormone Response to Naloxone in Hypertension Development (1989) (62)
- The preeminent role of early untoward experience on vulnerability to major psychiatric disorders: the nature-nurture controversy revisited and soon to be resolved (1999) (62)
- Estimates of Serotonin and Norepinephrine Transporter Inhibition in Depressed Patients Treated with Paroxetine or Venlafaxine (2008) (62)
- Glucocorticoid receptors in depression. (1995) (61)
- CSF somatostatin in Alzheimer's disease and major depression: Relationship to hypothalamic-pituitary-adrenal axis and clinical measures (1993) (61)
- HOT TOPICS (2012) (61)
- Exploratory structural equation modeling of resting-state fMRI: Applicability of group models to individual subjects (2009) (61)
- The treatment of bipolar depression. (2000) (60)
- The role of hormones in depression. (1977) (60)
- Comorbidity of mood and anxiety disorders: the rule, not the exception? (2002) (60)
- Behavioral effects of hypothalamic hypophysiotropic hormones, neurotensin, substance P and other neuropeptides. (1984) (60)
- The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis. (1987) (59)
- Neurotensin: an endogenous antipsychotic? (2002) (59)
- VNS Therapy in Treatment-Resistant Depression: Clinical Evidence and Putative Neurobiological Mechanisms (2006) (59)
- Anticonvulsants in the treatment of bipolar disorder. (1992) (59)
- Differences in adverse childhood experiences (ACEs) and quality of physical and mental health between transgender and cisgender sexual minorities. (2019) (58)
- Stress-induced alterations in neurotensin, somatostatin and corticotropin-releasing factor in mesotelencephalic dopamine system regions (1987) (58)
- The effects of neuropeptides on discrete-trial conditioned avoidance responding (1982) (58)
- Metabolic syndrome, major depression, generalized anxiety disorder, and ten-year all-cause and cardiovascular mortality in middle aged and elderly patients. (2015) (57)
- Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome. (1989) (57)
- DECREASED BRAINSTEM AND PUTAMEN SERT BINDING POTENTIAL IN DEPRESSED SUICIDE ATTEMPTERS USING [11C]‐ZIENT PET IMAGING (2013) (57)
- Potential Corticotropin‐Releasing Factor Pathways in the Rat Brain as Determined by Bilateral Electrolytic Lesions of the Central Amygdaloid Nucleus and the Paraventricular Nucleus of the Hypothalamus (1993) (56)
- Anatomy and Mechanisms of Neurotensin‐Dopamine Interactions in the Central Nervous System (1995) (56)
- Alterations in the hypothalamic-pituitary-adrenal axis in a proposed animal model of depression with genetic muscarinic supersensitivity. (1991) (55)
- Advances in the treatment of depression (2011) (55)
- Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Affective Disorders (2003) (54)
- Cytoprotective effect of centrally administered neurotensin on stress-induced gastric ulcers. (1982) (54)
- Neuropeptides in Alzheimer's disease: a postmortem study (1989) (54)
- Corticotropin‐Releasing Factor (CRF), CRF‐Binding Protein (CRF‐BP), and CRF/CRF‐BP Complex in Alzheimer's Disease and Control Postmortem Human Brain (1997) (54)
- Neurotensin, schizophrenia, and antipsychotic drug action. (2004) (54)
- An ever-increasing pharmacopoeia for the management of patients with bipolar disorder. (2000) (54)
- Elevated CSF dynorphin A [1-8] in Tourette's syndrome. (1988) (54)
- Several stressors fail to reduce adult hippocampal neurogenesis (2011) (54)
- Treatment of posttraumatic stress disorder with phenytoin: an open-label pilot study. (2004) (53)
- Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study. (1990) (53)
- Paroxetine binding to the rat norepinephrine transporter in vivo (2000) (53)
- CSF concentrations of neurotensin in schizophrenia: an investigation of clinical and biochemical correlates (1994) (53)
- Plasma dexamethasone concentrations and the dexamethasone suppression test (1990) (53)
- Functional brain imaging: twenty-first century phrenology or psychobiological advance for the millennium? (1999) (53)
- Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone. (2000) (52)
- Erratum: The neural correlates of social anxiety disorder and response to pharmacotherapy (Neuropsychopharmacology (2006) 31 (2243-2253) DOI: 10.1038/sj.npp.1301053) (2006) (52)
- Improving antidepressant adherence. (2003) (52)
- Neurotensin induces catalepsy in mice (1982) (52)
- Prednisone augmentation in treatment‐resistant depression with fatigue and hypocortisolaemia: A case series (2000) (51)
- Endocrine and behavioral effects of airpuff-startle in rats (1996) (51)
- Ontogeny of Brain Neurotensin in the Rat: A Radioimmunoassay Study (1984) (50)
- Thyrotropin-releasing hormone and amphetamine produce different patterns of behavioral excitation in rats. (1981) (50)
- Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. (2007) (50)
- The role of serotonin in the pathophysiology of depression: as important as ever. (2009) (50)
- Ketamine-xylazine-acepromazine anesthesia and postoperative recovery in rats. (2006) (49)
- Effects of short- and long-term haloperidol administration and withdrawal on regional brain cholecystokinin and neurotensin concentrations in the rat (1989) (49)
- The electrophysiological actions of neurotensin in the central nervous system. (1991) (49)
- The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression (2006) (49)
- Growth hormone-releasing factor stimulation test in depression. (1988) (49)
- Reduction of cerebellar volume in major depression: A controlled MRI study (1993) (48)
- The Effects of Chronic Treatment with the Mood Stabilizers Valproic Acid and Lithium on Corticotropin-Releasing Factor Neuronal Systems (2003) (48)
- The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases (2007) (48)
- Neurochemical alterations in Rett syndrome. (1993) (48)
- Modification of the actions of ethanol by centrally active peptides (1981) (48)
- Double-blind multicenter comparison of fluvoxamine versus sertraline in the treatment of depressed outpatients (1995) (48)
- Neurotensin-Deficient Mice Have Deficits in Prepulse Inhibition: Restoration by Clozapine but Not Haloperidol, Olanzapine, or Quetiapine (2005) (48)
- The Effect of Early Life Stress on Adult Psychiatric Disorders. (2019) (48)
- One stressful event blocks multiple actions of diazepam for up to at least a month (1988) (48)
- The American Psychiatric Association Publishing Textbook of Psychopharmacology (2017) (48)
- Cerebrospinal Fluid Corticotropin-Releasing Factor (CRF) and Vasopressin Concentrations Predict Pituitary Response in the CRF Stimulation Test: A Multiple Regression Analysis (2003) (47)
- Asymmetrical contribution of brain structures to treatment-resistant depression as illustrated by effects of right subgenual cingulum stimulation. (2010) (47)
- Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine (1986) (47)
- Handbook of Clinical Psychoneuroendocrinology (1987) (47)
- The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty? (2020) (47)
- Corticotropin-releasing factor concentrations exhibit an apparent diurnal rhythm in hypothalamic and extrahypothalamic brain regions: differential sensitivity to corticosterone. (1990) (46)
- Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain. (2000) (46)
- The CRF System as a Therapeutic Target for Neuropsychiatric Disorders. (2016) (46)
- Biochemical and histochemical evidence for the existence of a tuberoinfundibular cholinergic pathway in the rat (1977) (46)
- Duloxetine for the treatment of major depressive disorder. (2002) (46)
- Evidence for a tonic facilitatory influence of substance P on dopamine release in the nucleus accumbens (1986) (46)
- Corticotropin-Releasing Factor and the Psychobiology of Early-Life Stress (2007) (46)
- Effects of gender and social isolation on electroencephalogram and neuroendocrine parameters in rats (1993) (46)
- Modification of pentobarbital-induced sedation by natural and synthetic peptides (1978) (46)
- The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous system. (1994) (45)
- Synchronized Maternal-Infant Elevations of Primate CSF CRF Concentrations in Response to Variable Foraging Demand (2005) (45)
- Pharmacological Treatment of Anxiety Disorders: The Role of the HPA Axis (2020) (45)
- Lithium augmentation of antidepressants in treatment-refractory depression. (1998) (45)
- Depression really does hurt your heart: stress, depression, and cardiovascular disease. (2000) (45)
- Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia. (2008) (45)
- Are CRF receptor antagonists potential antidepressants? (2001) (44)
- Neurotensin, Antipsychotic Drugs, and Schizophrenia (1992) (44)
- Paroxetine: An Overview of the Efficacy and Safety of a New Selective Serotonin Reuptake Inhibitor in the Treatment of Depression (1993) (44)
- Neuroimaging Biomarkers in Schizophrenia. (2021) (44)
- Hemispheric specialization in affective responses, cerebral dominance for language, and handedness Lateralization of emotion, language, and dexterity (2015) (44)
- Radiologic correlates of antidepressant-induced delirium: the possible significance of basal-ganglia lesions. (1989) (43)
- Novel treatments of schizophrenia: targeting the neurotensin system. (2006) (43)
- Critical issues in the treatment of affective disorders (1995) (43)
- Neurotensin and bombesin: differential effects on body temperature of mice after intracisternal administration (1980) (43)
- Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants (2016) (43)
- High Affinity Choline Transporter Status in Alzheimer's Disease Tissue from Rapid Autopsy a (1996) (43)
- Association of Prospective Risk for Chronic PTSD Symptoms With Low TNFα and IFNγ Concentrations in the Immediate Aftermath of Trauma Exposure. (2019) (43)
- Reduced glucocorticoid receptors: consequence or cause of depression? (2006) (43)
- Cerebrospinal Fluid Concentrations of Biogenic Amines and Corticotropin-releasing Factor in Adolescent Non-human Primates as a Function of the Timing of Adverse Early Rearing (2002) (43)
- New directions in the development of antidepressants: the interface of neurobiology and psychiatry (2002) (43)
- The neurobiology of social anxiety disorder: the relevance of fear and anxiety (2003) (42)
- An Evaluation of Risperidone Drug Interactions (2001) (42)
- ■ REVIEW : Corticotropin-releasing Factor, Stress, and Depression (1997) (42)
- Benzodiazepine Sensitivity in Panic Disorder: Effects of Chronic Alprazolam Treatment (1995) (42)
- Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation (2007) (42)
- Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome. (1992) (41)
- Use of the dexamethasone suppression test using DSM-III criteria on an inpatient psychiatric unit. (1983) (41)
- Platelet activation and secretion in patients with major depression, thoracic aortic atherosclerosis, or renal dialysis treatment (2002) (41)
- Recognizing the importance of childhood maltreatment as a critical factor in psychiatric diagnoses, treatment, research, prevention, and education (2021) (41)
- The preeminent role of childhood abuse and neglect in vulnerability to major psychiatric disorders: toward elucidating the underlying neurobiological mechanisms. (2014) (41)
- Peptides and psychoneuroendocrinology. A perspective. (1978) (41)
- Postmortem and Cerebrospinal Fluid Studies of Corticotropin‐releasing Factor in Humans a (1996) (41)
- Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions. (1998) (40)
- The Depressed Suicidal Patient (2001) (40)
- Maternal–Infant Response to Variable Foraging Demand in Nonhuman Primates (2006) (40)
- CSF corticotropin-releasing factor is not affected in panic disorder (1993) (40)
- The role of the adrenal gland in cytoprotection against stress‐induced gastric ulcers in rats (1984) (40)
- Direct evidence that the arcuate nucleus-median eminence tuberoinfundibular system is not of primary importance in the feedback regulation of luteinizing hormone and follicle-stimulating hormone secretion in the castrated rat. (1978) (40)
- Personalized medicine: Prediction of disease vulnerability in mood disorders (2016) (40)
- Electroconvulsive therapy of depression in patients with white matter hyperintensity (1987) (39)
- Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial (2014) (39)
- Identification of a Signaling Mechanism by Which the Microbiome Regulates Th17 Cell-Mediated Depressive-Like Behaviors in Mice. (2020) (39)
- Early-life stress, corticotropin-releasing factor, and serotonin transporter gene: A pilot study (2011) (39)
- Understanding the Pathophysiology of Postpartum Depression: Implications for the Development of Novel Treatments (2008) (39)
- A Novel Transgenic Mouse for Gene-Targeting Within Cells That Express Corticotropin-Releasing Factor (2010) (39)
- The neurobiological basis of mixed depression-anxiety states. (1993) (39)
- Early life stress and macaque amygdala hypertrophy: preliminary evidence for a role for the serotonin transporter gene (2014) (39)
- Emerging antidepressants to treat major depressive disorder. (2014) (38)
- Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study. (2006) (38)
- Cerebrospinal fluid correlates of depression in Huntington's disease. (1988) (38)
- Predictors of neonatal hypothalamic–pituitary–adrenal axis activity at delivery (2011) (38)
- A health care workers mental health crisis line in the age of COVID‐19 (2020) (38)
- Neurotensin: Distribution of hypothermic response in mammalian and submammalian vertebrates (1979) (37)
- Neuroendocrine effects of diazepam in panic and generalized anxiety disorders (1991) (37)
- Thyrotropin‐Releasing Hormone (TRH), the Thyroid Axis, and Affective Disorder a (1989) (37)
- Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate. (1990) (37)
- Alterations in platelet serotonin transporter binding in women with postpartum onset major depression. (2004) (37)
- SUBNORMAL CSF LEVELS OF NEUROTENSIN IN A SUBGROUP OF SCHIZOPHRENICS AND NORMALIZATION AFTER NEUROLEPTIC TREATMENT (1982) (37)
- Personalized Medicine and Mood Disorders. (2015) (37)
- Alzheimer's-disease-related protein in geriatric schizophrenic patients with cognitive impairment. (1993) (37)
- Growth hormone response to clonidine in adversely reared young adult primates: relationship to serial cerebrospinal fluid corticotropin-releasing factor concentrations (2000) (37)
- Synthesis and biological evaluation of [11C]talopram and [11C]talsupram: candidate PET ligands for the norepinephrine transporter. (2004) (37)
- Neurotensin studies in alcohol naive, preferring and non-preferring rats ∗ Presented in part at the 1998 ACNP Meeting. ∗ (1999) (37)
- Novel targets for antidepressant therapies (2008) (36)
- The diagnosis of major depression in patients with cancer: a comparative approach. (2006) (36)
- Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial (2013) (36)
- THE MANIFOLD ACTIONS OF NEUROTENSIN: A FIRST SYNTHESIS * (1982) (36)
- A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials (2021) (36)
- Interactions between "handling" and acrylamide on endocrine responses in rats. (1982) (36)
- Interaction of stress, corticotropin-releasing factor, arginine vasopressin and behaviour. (2014) (36)
- Effects of Sodium Valproate on Corticotropin-Releasing Factor Systems in Rat Brain (2001) (36)
- Relationship of serum TSH concentration and antithyroid antibodies to diagnosis and DST response in psychiatric inpatients. (1987) (36)
- The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal. (2007) (36)
- Neuropeptides, Dopamine, and Schizophrenia a (1988) (36)
- “Normal Pressure” Pseudotumor Cerebri (1996) (35)
- The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain. (1991) (35)
- Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats. (1991) (35)
- MRI of corpus callosum and septum pellucidum in depression (1991) (35)
- Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression. (2019) (35)
- Clinical Response Predictors in a Double-Blind, Placebo-Controlled Trial of Fluoxetine for Geriatric Major Depression (1995) (35)
- Bombesin-induced locomotor hyperactivity: evaluation of the involvement of the mesolimbic dopamine system (1984) (35)
- Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala (2013) (34)
- Neuropharmacology of paroxetine. (2003) (34)
- NEUROANATOMICAL SITES OF ACTION OF NEUROTENSIN * (1982) (34)
- Recent Findings in the Pathophysiology of Depression (2008) (33)
- Attention-Deficit and Disruptive Behavior Disorders (2014) (33)
- A controlled trial of venlafaxine in trichotillomania: interim phase I results. (1998) (33)
- Peptides and nociception. (1984) (33)
- Behavioral effects of neurotensin in the open field: structure-activity studies (1986) (32)
- EFFICACY AND LONG‐TERM CLINICAL OUTCOME OF COMORBID POSTTRAUMATIC STRESS DISORDER AND MAJOR DEPRESSIVE DISORDER AFTER ELECTROCONVULSIVE THERAPY (2016) (32)
- Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study. (2014) (32)
- Candidate Biomarkers of Suicide Crisis Syndrome: What to Test Next? A Concept Paper (2019) (32)
- Dr. Nemeroff and the Publishers Reply (1997) (32)
- Mode matches in hydrophobic free energy eigenfunctions predict peptide-protein interactions. (1998) (32)
- Changes of CSF neuropeptides after environmental stimulation in dementia (1985) (32)
- Childhood trauma and METH abuse among men who have sex with men: Implications for intervention. (2016) (32)
- Monosodium glutamate lesions in rat hypothalamus studied by immunohistochemistry for gonadotropin releasing hormone, neurotensin, tyrosine hydroxylase, and glutamic acid decar☐ylase and by autoradiography for [3H]estradiol (1984) (31)
- Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment (1992) (31)
- The Detection of Depression by Patient Self-Report in Women with Gynecologic Cancer (1991) (31)
- Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter. (2009) (31)
- Thyrotropin-releasing hormone (TRH) and its beta-alanine analogue: potentiation of the anticonvulsant potency of phenobarbital in mice. (1975) (31)
- Neurosarcoidosis as a cause of refractory psychosis: a complicated case report. (1998) (31)
- Apolipoprotein E-epsilon 4 frequency in geriatric depression. (1996) (31)
- Emerging treatments for depression (2006) (31)
- The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder. (2012) (30)
- Interactions of neurotensin with dopamine-containing neurons in the central nervous system (1988) (30)
- Bombesin-like immunoreactivity in the central nervous system of capsaicin-treated rats: a radioimmunoassay and immunohistochemical study (1985) (30)
- Virally Mediated Increased Neurotensin 1 Receptor in the Nucleus Accumbens Decreases Behavioral Effects of Mesolimbic System Activation (2005) (30)
- Alterations in regional brain neurotensin concentrations produced by atypical antipsychotic drugs (1991) (30)
- Cortisol responses following placebo and alcohol in Asians with different ALDH2 genotypes. (1994) (29)
- Unipolar depression. (2020) (29)
- Cancer and Depression: Theory and Treatment (1997) (29)
- Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation (2021) (29)
- Peptides, Hormones and Behavior (1984) (29)
- Neurotensin, a brain and gastrointestinal peptide. (1982) (29)
- Adrenocortical sensitivity to low-dose ACTH administration in depressed patients (1990) (29)
- Role of the autonomic nervous system in the cytoprotective effect of neurotensin against gastric stress ulcers in rats (1985) (29)
- The Bipolar Book History, Neurobiology, and Treatment (2015) (29)
- The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies. (1995) (28)
- Concurrent use of antidepressants and propranolol: case report and theoretical considerations. (1983) (28)
- HUMAN BRAIN DISTRIBUTION OF NEUROTENSIN IN NORMALS, SCHIZOPHRENICS, AND HUNTINGTON'S CHOREICS * (1982) (28)
- The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration. (1991) (28)
- Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests (2016) (28)
- Chronic haloperidol-induced changes in regional dopamine release and metabolism and neurotensin content in rats (1995) (28)
- Neuropeptides and Alzheimer's Disease (1990) (28)
- The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal (2007) (28)
- A Neuroendocrine View of ECT. (1989) (28)
- Erratum: Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma (Proceedings of the National Academy of Sciences of the United States of America (November 25, 2003) 100, 24 (14293-14296)) (2005) (28)
- Effect of Chronic Treatment with Thyrotropin-Releasing Hormone (TRH) or an Analog of TRH (Linear β-Alanine TRH) on the Hypothalamic-Pituitary-Thyroid Axis (1980) (28)
- The diagnosis and treatment of mania in the elderly. (1996) (27)
- Neuropeptides and Psychiatric Disorders (1991) (27)
- Compartmental Modeling of 11C-HOMADAM Binding to the Serotonin Transporter in the Healthy Human Brain (2008) (27)
- Neurotransmitters and neuropeptides in Alzheimer's disease. (1991) (27)
- Carbon-11 HOMADAM: a novel PET radiotracer for imaging serotonin transporters. (2005) (27)
- Augmentation regimens for depression. (1991) (27)
- DNA methylation levels are associated with CRF1 receptor antagonist treatment outcome in women with post-traumatic stress disorder (2018) (27)
- Occult subcortical magnetic resonance findings in elderly depressives (1991) (27)
- Comparison of the analeptic potency of TRH, ACTH 4–10, LHRH, and related peptides (1976) (26)
- Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity (2017) (26)
- Cardiac Arrest and Cardiopulmonary Resuscitation Dysregulates the Hypothalamic–Pituitary–Adrenal Axis (2009) (26)
- Social media recruitment for mental health research: A systematic review. (2020) (26)
- Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein. (2017) (26)
- Microinjection of neurotensin into the ventral tegmental area produces hypothermia: Evaluation of dopaminergic mediation (1985) (26)
- The Clinical Pharmacology and Use of Paroxetine, a New Selective Serotonin Reuptake Inhibitor (1994) (26)
- Involvement of neuropeptide systems in schizophrenia: human studies. (2007) (26)
- Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders (2017) (25)
- Early life stress affects cerebral glucose metabolism in adult rhesus monkeys (Macaca mulatta) (2012) (25)
- The effect of intracisternally administered bombesin on cysteamine-induced duodenal ulcers in rats. (1982) (25)
- WHITHER KETAMINE AS AN ANTIDEPRESSANT: PANACEA OR TOXIN? (2016) (25)
- Effects op acute administration of monosodium-l-glutamate (MSG), atropine or haloperidol on anterior pituitary hormone secretion in the rat (1978) (25)
- Neuroanatomical changes and hypothalamo-pituitary-adrenal axis abnormalities (1989) (25)
- Regional Neuropeptide Pathology in Alzheimer's Disease: Corticotropin-Releasing Factor and Somatostatin. (1998) (24)
- Postnatal development of regional binding of corticotropin-releasing factor and adenylate cyclase activity in the rat brain (1992) (24)
- The impact of early trauma on response to psychotherapy (2005) (24)
- 72 MOLECULAR AND CELLULAR MECHANISMS IN DEPRESSION (2002) (24)
- Antidepressant Drug-Drug Interactions: Clinical Relevance and Risk Management (2007) (24)
- Adrenocortical sensitivity to ACTH in humans (1988) (24)
- Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptor. (2001) (24)
- Inverse relationship between CSF TRH concentrations and the TSH response to TRH in abstinent alcohol-dependent patients. (1991) (24)
- New-onset psychosis associated with dandy-walker variant in an adolescent female patient. (2012) (24)
- Synthesis and Characterization of Iodine-123 Labeled 2β-Carbomethoxy-3β-(4‘-((Z)-2-iodoethenyl)phenyl)nortropane. A Ligand for in Vivo Imaging of Serotonin Transporters by Single-Photon-Emission Tomography (2003) (24)
- Effects of neurotensin receptor antagonism on latent inhibition in Sprague-Dawley rats (2002) (23)
- Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer's Disease. (2017) (23)
- Upregulation of Striatal Dopamine-2 Receptors in Brattleboro Rats with Prepulse Inhibition Deficits (2006) (23)
- The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders. (1993) (23)
- Cerebrospinal Fluid Substance P-Like Immunoreactivity Correlates with Aggression in Personality Disordered Subjects (2012) (23)
- Corticotropin-releasing factor (CRF) and major depression: Towards an integration of psychology and neurobiology in depression research (2013) (23)
- Caudate Hyperintensities in Elderly Depressed Patients With Neuroleptic-Induced Parkinsonism (1991) (22)
- Future prospects in depression research (2006) (22)
- Neurotensin-induced antinociception and hypothermia in mice: antagonism by TRH and structural analogs of TRH (1984) (22)
- Decision-making in diabetes mellitus type 1. (2013) (22)
- A comparison of cocaine and its metabolite norcocaine: Effects on locomotor activity (1987) (22)
- Thyrotropin-releasing hormone and amphetamine: a comparison of pharmacological profiles in animals. (1979) (22)
- Inflammation and Mood Disorders: Proinflammatory Cytokines and the Pathogenesis of Depression (2010) (22)
- Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802. (1992) (21)
- Evidence for biological activity of two N-terminal fragments of neurotensin, neurotensin1–8 and neurotensin1–10 (1984) (21)
- Microembolism infarcts lead to delayed changes in affective-like behaviors followed by spatial memory impairment (2012) (21)
- Cortical and subcortical neuropeptides in Alzheimer's disease (1994) (21)
- Differences in CSF concentrations of thyrotropin-releasing hormone in depressed patients and normal subjects: negative findings. (1994) (21)
- Reduced inhibitory effect of imipramine on radiolabeled serotonin uptake into platelets in geriatric depression (1989) (21)
- Risks and Benefits of Cannabis and Cannabinoids in Psychiatry. (2021) (21)
- Effects of the isomers of N-n-propylnorapomorphine and haloperidol on regional concentrations of neurotensin in rat brain. (1991) (21)
- The corticotropin releasing factor stimulation test in patients with major depression: Relationship to dexamethasone suppression test results (1993) (21)
- Corticotropin-Releasing Factor (1989) (21)
- Pharmacological treatments for unipolar depression. (2007) (20)
- Changes in the Vascular Area Fraction of the Hippocampus and Amygdala are Induced by Prenatal Dexamethasone and/or Adult Stress (2010) (20)
- Early Life Stress and Substance Use Disorders: Underlying Neurobiology and Pathways to Adverse Outcomes (2020) (20)
- Steroid-Induced Psychosis in the Pediatric Population: A New Case and Review of the Literature. (2018) (20)
- Tricyclics and newer antidepressant medications: Treatment options for treatment‐resistant depressions (1994) (20)
- Spontaneous Withdrawal from the Triazolobenzodiazepine Alprazolam Increases Cortical Corticotropin-Releasing Factor mRNA Expression (2004) (20)
- Combined effects of genotype and childhood adversity shape variability of DNA methylation across age (2021) (20)
- The Preeminence of Early Life Trauma as a Risk Factor for Worsened Long-Term Health Outcomes in Women (2015) (20)
- The effects of sertraline on psychopathic traits (2011) (20)
- Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions. (1989) (20)
- Ontogeny of the hypothermic response to centrally administered neurotensin in rats. (1982) (20)
- Neurotensin Receptor Antagonist SR 142948A Alters Fos Expression and Extrapyramidal Side Effect Profile of Typical and Atypical Antipsychotic Drugs (2004) (20)
- NEUROTENSIN-NEUROLEPTIC SIMILARITIES: AN EXAMPLE OF PEPTIDE-CATECHOLAMINE INTERACTIONS (1979) (20)
- Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia (1994) (20)
- Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults (2004) (20)
- Monosodium L-glutamate-induced convulsions: temporary alteration in blood-brain barrier permeability to plasma proteins. (1975) (19)
- Neurotensin and the Mesocorticolimbic Dopamine System a (1988) (19)
- Psychotherapy or medication for depression? Using individual symptom meta-analyses to derive a Symptom-Oriented Therapy (SOrT) metric for a personalised psychiatry (2020) (19)
- Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders (2002) (19)
- Suicidal ideation and behavior in institutions of higher learning: A latent class analysis. (2017) (19)
- Elevation of CSF somatostatin concentrations in mania. (1995) (19)
- QUETIAPINE IMPROVES PSYCHOTIC SYMPTOMS ASSOCIATED WITH PARKISON's DISEASE (1999) (19)
- Do neurotensin receptor agonists represent a novel class of antipsychotic drugs? (2003) (19)
- The Role of Corticotropin-Releasing Factor in the Pathophysiology of Psychiatric Disorders (1993) (19)
- Nocturnal and early morning secretion of ACTH and cortisol in humans (1990) (19)
- Laboratory models of post-traumatic stress disorder: The elusive bridge to translation (2022) (18)
- BMY 14802, a potential antipsychotic drug, increases expression of proneurotensin mRNA in the rat striatum. (1992) (18)
- Personalized Medicine in Psychiatry: Back to the Future (2017) (18)
- Evaluating the Machine Learning Literature: A Primer and User's Guide for Psychiatrists. (2021) (18)
- Cerebrospinal fluid TRH immunoreactivity in anorexia nervosa (1994) (18)
- Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter. (2008) (17)
- The effect of the stereoisomers of butaclamol on neurotensin content in discrete regions of the rat brain. (1988) (17)
- Neuropeptides in CSF and post-mortem brain tissue of normal controls, schizophrenics and huntington's choreics (1985) (17)
- Regulation of Corticotropin‐Releasing Factor Secretion and Synthesis in the Human Neuroblastoma Clones‐ BE(2)‐M17 and BE(2)‐C (1995) (17)
- Response rate profiles for major depressive disorder: Characterizing early response and longitudinal nonresponse (2018) (17)
- Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder. (1990) (17)
- Depression as a systemic disease (2017) (17)
- A critical evaluation of cysteamine as a tool to deplete somatostatin in the rat central nervous system. (1989) (17)
- Somatic symptoms in treatment‐naïve Hispanic and non‐Hispanic patients with major depression (2019) (17)
- Tritiated platelet imipramine binding and treatment response in depressed outpatients (1993) (17)
- CSF monoamine metabolites in chronic pain (1987) (17)
- Effect of prostaglandin synthesis inhibitors on neurotensin and sodium salicylate-induced gastric cytoprotection in rats. (1983) (17)
- Endogenous neurotensin is involved in estrous cycle related alterations in prepulse inhibition of the acoustic startle reflex in female rats (2008) (17)
- Persistent anxiolytic affects after chronic administration of the CRF1 receptor antagonist R121919 in rats (2011) (17)
- Neuropeptides and schizophrenia. (1986) (17)
- Effects of Duloxetine on Norepinephrine and Serotonin Transporter Activity in Healthy Subjects (2014) (16)
- The Psychobiology of Neurotensin (1988) (16)
- Overview of the safety of citalopram. (2003) (16)
- Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features (2009) (16)
- CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia (1992) (16)
- Neurobiological Pathways Involved in Fear, Stress, and PTSD (2018) (16)
- Intracameral administration of neurotensin induces miosis in the rabbit (1983) (16)
- Cerebrospinal fluid neuropeptides in dementia (1992) (16)
- Increase in plasma beta-endorphin-like immunoreactivity at parturition in normal women. (1983) (16)
- Growth hormone response to growth hormone releasing factor in Alzheimer's disease. (1989) (15)
- Follow-Up of Monotherapy Remitters in the PReDICT Study: Maintenance Treatment Outcomes and Clinical Predictors of Recurrence (2018) (15)
- Neurobiology and Genetics of Generalized Anxiety Disorder (2011) (15)
- Reduced hypothalamic content of immunoreactive LH-RH-like activity in genetically obeseob/ob mice (1978) (15)
- Substance P, thyrotropin-releasing hormone, and monoamine metabolites in cerebrospinal fluid in sleep apnea patients. (1992) (15)
- Apolipoprotein E ε4 (1994) (15)
- Neonatal treatment with monosodium glutamate does not alter grooming behavior induced by novelty or adrenocorticotropic hormone. (1985) (15)
- Cerebrospinal fluid thyrotropin-releasing hormone concentrations in alcoholics and normal controls (1990) (15)
- Corticotropin-Releasing Factor Antagonists (1999) (15)
- Activation of brain areas concerned with social cognition during moral decisions is abnormal in schizophrenia patients and unaffected siblings. (2013) (15)
- The curiously strong relationship between cardiovascular disease and depression in the elderly. (2008) (14)
- Selective serotonin reuptake inhibitors in the treatment of depression (1996) (14)
- Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy (2008) (14)
- Effects of a cognitive stress challenge on myocardial perfusion and plasma cortisol in coronary heart disease patients with depression. (2009) (14)
- PSYCHONEUROIMMUNOENDOCRINOLOGY: THE BIOLOGICAL BASIS OF MIND–BODY PHYSIOLOGY AND PATHOPHYSIOLOGY (2013) (14)
- Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response (2011) (14)
- Stress, menopause and vulnerability for psychiatric illness (2007) (14)
- Platelet [3H]-imipramine binding and leukoencephalopathy in geriatric depression (1991) (14)
- RU486 in depression (1992) (14)
- Erratum: VNS therapy in treatment-resistant depression: Clinical evidence and putative neurobiological mechanisms (Neuropsychopharmacology (2006) 31 (1345-1355) DOI: 10.1038/sj.npp.1301082) (2006) (13)
- Monosodium glutamate-induced neurotoxicity: Review of the literature and call for further research (1980) (13)
- Progress in the battle with the black dog: advances in the treatment of depression. (2001) (13)
- Persistent Auditory Hallucinations That Are Unresponsive to Antipsychotic Drugs (2006) (13)
- The pervasive and persistent neurobiological and clinical aftermath of child abuse and neglect. (2013) (13)
- Substance dependence. (1998) (13)
- Effects of Chronic Ethanol and Benzodiazepine Treatment and Withdrawal on Corticotropin‐releasing Factor Neural Systems a (1992) (13)
- Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat. (1996) (13)
- Treatment of affective disorders in cardiac disease (2015) (13)
- Psychiatric Research Report (2006) (13)
- Neuroendocrinology of depression (1993) (13)
- Behavioral effects of the CRF1 receptor antagonist R121919 in rats selectively bred for high and low activity in the swim test (2008) (13)
- The effects of glutamate receptor agonists on neurotensin release using in vivo microdialysis. (2001) (13)
- A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease (1991) (13)
- The Neurochemistry of Depressive Disorders: Clinical Studies (2011) (13)
- Challenges in the Classification and Treatment of Trichotillomania (1998) (13)
- Biomarker-Guided Tailored Therapy. (2019) (13)
- Preclinical and clinical studies with corticotropin-releasing factor: implications for affective disorders. (1988) (12)
- Interdose Elevation in Plasma Cortisol During Chronic Treatment with Alprazolam but not Lorazepam in the Elderly (2004) (12)
- Alterations in Alzheimer's disease-associated protein in Alzheimer's disease frontal and temporal cortex. (1991) (12)
- Action of Three Ectopeptidases on Corticotropin-Releasing Factor: Metabolism and Functional Aspects (2003) (12)
- Benzodiazepine Receptor Ligands with Different Intrinsic Efficacies Alter Ethanol Intake in Alcohol-Nonpreferring (NP) Rats (1996) (12)
- Differential Effects of Conditioned and Unconditioned Stress on the Neurotensin Content of Dopamine Cell Body Groups of the Ventral Mesencephalon (1992) (12)
- Interaction of neurotensin with prostaglandin E2 and prostaglandin synthesis inhibitors: effects on colonic temperature in mice (1982) (12)
- Effects of neonatal treatment with 6-aminonicotinamide on basal and isoproterenol-stimulated ornithine decarboxylase activity in cerebellum of the development rat. (1985) (12)
- THE PRESYNAPTIC SEROTONIN UPTAKE SITE IN DEPRESSION (1992) (12)
- Disrupted functional connectivity of the locus coeruleus in healthy adults with parental history of Alzheimer's disease. (2020) (12)
- Neuro-transcriptomic signatures for mood disorder morbidity and suicide mortality. (2020) (12)
- Cerebrospinal fluid concentrations of neurotensin and corticotropin-releasing factor in pediatric patients. (1989) (12)
- The BE (2)-M17 neuroblastoma cell line synthesizes and secretes corticotropin-releasing factor (1994) (12)
- Effects of CI‐943, a potential antipsychotic drug, and haloperidol on regional brain neurotensin concentrations (1991) (12)
- Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents (1987) (12)
- Brain-Body Interactions: The Physiological Impact of Mental Processes — The Neurobiology of the Stress Response (2009) (12)
- Adrenal function in major depression (1995) (12)
- Posttraumatic Stress Disorder: A State-of-the-Science Review (2009) (12)
- A meta-analysis of conditioned fear generalization in anxiety-related disorders (2022) (11)
- Fast feedback regulation of acth by cortisol (1991) (11)
- The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion (2012) (11)
- Fostering foster care outcomes: quality of intervention matters in overcoming early adversity. (2008) (11)
- The dexamethasone suppression test in organic affective syndrome. (1984) (11)
- The Moderating Effect of Resilience on the Relationship between Adverse Childhood Experiences (ACEs) and Quality of Physical and Mental Health among Adult Sexual and Gender Minorities (2020) (11)
- Prior trauma‐related experiences predict the development of posttraumatic stress disorder after a new traumatic event (2020) (11)
- Dexamethasone suppression test identifies a subset of elderly depressed patients with reduced platelet serotonin transport and resistance to imipramine inhibition of transport (1997) (11)
- A concise guide to understanding suicide : epidemiology, pathophysiology, and prevention (2014) (11)
- CRF receptor antagonists: A new approach to the treatment of depression (2001) (11)
- The role of peptides in affective disorders: a review. (1987) (11)
- Somatostatin and Behavior: Preclinical and Clinical Studies (1987) (11)
- The anhedonia hypothesis of neuroleptic drug action: Basic and clinical considerations (1982) (10)
- Executive functioning in cognitively normal middle-aged offspring of late-onset Alzheimer's disease patients. (2019) (10)
- The neurobiology of aging and the neurobiology of depression: Is there a relationship? (1988) (10)
- Pattern of brain activation during social cognitive tasks is related to social competence in siblings discordant for schizophrenia. (2014) (10)
- Cerebrospinal-fluid neuropeptides: a biochemical subgrouping approach. (1992) (10)
- New Vistas in the Management of Treatment-Refractory Psychiatric Disorders: Genomics and Personalized Medicine (2010) (10)
- Persistent auditory hallucinations that are unresponsive to antipsychotic drugs. (2006) (10)
- Chronic Continuous or Intermittent Infusion of Cocaine Differentially Alter the Concentration of Neurotensin-like Immunoreactivity in Specific Rat Brain Regions (1993) (10)
- Sex- and estrous cycle-related differences in the effects of acute antipsychotic drug administration on neurotensin-containing neurons in the rat brain. (2000) (10)
- Brain Structural and Amyloid Correlates of Recovery From Semantic Interference in Cognitively Normal Individuals With or Without Family History of Late-Onset Alzheimer's Disease. (2019) (10)
- The Role of Oxytocin in Early Life Adversity and Later Psychopathology: a Review of Preclinical and Clinical Studies (2018) (10)
- Recall accuracy for the symptoms of a major depressive episode among clinical trial participants. (2019) (10)
- Effects of anticholinergic drugs on regional brain neurotensin concentrations. (1989) (10)
- Cortical thickness, brain metabolic activity, and in vivo amyloid deposition in asymptomatic, middle-aged offspring of patients with late-onset Alzheimer's disease. (2018) (10)
- SOMATOSTATIN: A NEUROPEPTIDE SYSTEM PATHOLOGICALLY ALTERED IN ALZHEIMER'S DISEASE AND DEPRESSION (1992) (10)
- The neuroendocrine effects of early life trauma (2010) (10)
- The Mesocorticolimbic Dopamine System. Annals of the New York Academy of Sciences. Volume 537 (1988) (9)
- Munchausen syndrome, depression, and the dexamethasone suppression test. (1984) (9)
- Current treatment options for insomnia. (2012) (9)
- The Long-Lasting Neurobiological Scars of Early-Life Stress: Implications for the Neurobiology of Depression (2019) (9)
- Is There a Relationship between Baseline and Treatment-Associated Changes in [3H]-IMI Platelet Binding and Clinical Response in Major Depression? (1996) (9)
- Neuropeptides and neurotransmitters in Alzheimer's disease: focus on corticotrophin releasing factor. (1991) (9)
- APOE: a risk factor for multiple disorders. (2012) (9)
- Clinical outcome of maintenance electroconvulsive therapy in comorbid Posttraumatic Stress Disorder and major depressive disorder. (2018) (9)
- Innovative Approach to Research Training: Research Colloquium for Junior Investigators (2011) (9)
- White matter fiber density abnormalities in cognitively normal adults at risk for late-onset Alzheimer's disease. (2020) (9)
- Underestimation of substance abuse in psychiatric patients by conventional hospital screening. (2014) (9)
- Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder. (2018) (9)
- Suicidal ideation and other persisting symptoms after CBT or antidepressant medication treatment for major depressive disorder (2018) (9)
- Lifetime Stress Accelerates Epigenetic Aging (2015) (9)
- Species differences in alpha 2-adrenergic regulation of platelet adenylate cyclase. (1991) (9)
- Integration of peripheral transcriptomics, genomics, and interactomics following trauma identifies causal genes for symptoms of post-traumatic stress and major depression (2021) (9)
- CSF thyrotropin-releasing hormone concentrations differ in patients with schizoaffective disorder from patients with schizophrenia or mood disorders. (2001) (9)
- Childhood maltreatment, prefrontal-paralimbic gray matter volume, and substance use in young adults and interactions with risk for bipolar disorder (2021) (9)
- Similarities and differences in the effects of centrally administered neurotensin and neuroleptics (1981) (9)
- The Medical Consequences of Child Abuse and Neglect (2009) (9)
- Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study. (2020) (8)
- Cerebrospinal fluid thyrotropin-releasing hormone concentrations in patients with anxiety disorders. (1993) (8)
- Management of Treatment-Resistant Major Psychiatric Disorders (2012) (8)
- Exposure to an Antisense Oligonucleotide Decreases Corticotropin‐Releasing Factor Receptor Binding in Rat Pituitary Cultures (1995) (8)
- Subcellular distribution of corticotropin-releasing-factor-like immunoreactivity in rat central nervous system. (1991) (8)
- Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care (1999) (8)
- Neuropeptides in psychiatric and neurological disorders (1988) (8)
- Alterations in cerebrospinal fluid concentrations of somatostatin-like immunoreactivity in chronic pain patients (1988) (8)
- Genetic Analysis of the Hypothalamic Neurotensin System (2006) (8)
- Early Life Trauma and Suicide (2014) (8)
- Transcriptome-wide association study of post-trauma symptom trajectories identified GRIN3B as a potential biomarker for PTSD development (2021) (8)
- Recent Advances in the Neurochemical Pathology of Alzheimer's Disease (1991) (8)
- Antagonization of the behavioral activation produced by direct stimulation of forebrain dopamine receptors caused by intraaccumbens injections of neurotensin. (1988) (8)
- Advancing the treatment of mood and anxiety disorders: the first 10 years' experience with paroxetine. (2003) (8)
- Neurobiological effects of early trauma. (1999) (8)
- Genetic analysis of the hypothalamic corticotropin-releasing factor system. (2005) (8)
- Corticotropin-releasing factor antagonists as novel psychotherapeutics (2000) (8)
- Interleukin‐1α induces corticotropin‐releasing factor secretion and synthesis from NPLC‐KC cells through various second messenger pathways (1994) (8)
- Striatal dopamine receptor plasticity in neurotensin deficient mice (2015) (8)
- P.1.189 Venlafaxine and SSRIs: Pooled remission analysis (2003) (8)
- Lithium to the Rescue (2016) (8)
- Lack of effect of chronically administered thyrotropin-releasing hormone (TRH) on regional rat brain tyrosine hydroxylase activity (1977) (8)
- Convergent neurobiological predictors of mood and anxiety symptoms and treatment response (2019) (7)
- Atypical antipsychotic drugs: Current status and future directions (1993) (7)
- Organic anxiety disorder. Iatrogenic hyperthyroidism. (1993) (7)
- Microtopographic distribution of neurotensin and catecholamine concentrations at the level of individual rat brain nuclei (1984) (7)
- Behavioural effects of hypothalamic peptides (1978) (7)
- Reply to 'Editorial policies on financial disclosure' (2003) (7)
- Managing Side Effects (2005) (7)
- HPA Axis Modulation in the Treatment of Mood Disorders (2013) (7)
- Trauma Spectrum Disorders (2006) (7)
- The biology of bipolar disorder (2000) (7)
- Neurotensin-dopamine interactions: relevance to schizophrenia and the action of antipsychotic drugs. (1991) (7)
- Lack of protection by pyridoxine or hydrazine pretreatment against monosodium L-glutamate-induced seizures (1975) (7)
- Clinicians on the front line: active management of depression and anxiety in primary care. (2006) (7)
- Neurobiology of psychiatric disorders (2012) (7)
- Sex Differences in Peritraumatic Inflammatory Cytokines and Steroid Hormones Contribute to Prospective Risk for Nonremitting Posttraumatic Stress Disorder (2021) (7)
- Cluster B personality symptoms in persons at genetic risk for schizophrenia are associated with social competence and activation of the right temporo-parietal junction during emotion processing (2014) (7)
- Implementation of Advanced Methods for Reproductive Pharmacovigilance in Autism: A Meta-Analysis of the Effects of Prenatal Antidepressant Exposure. (2020) (7)
- Is there a link between child abuse and neglect and anxiety disorders (2013) (7)
- Experimental studies on the ultrastructural localization of acetylcholinesterase in the mediobasal hypothalamus of the rat (1978) (7)
- From Semantic to Social Deficits: Dysfunction of the Nondominant Posterior Perisylvian Area in Schizophrenia. (2015) (7)
- The Problem of Treatment-Resistant Psychiatric Disorders (2012) (7)
- Neuropeptide-Dopamine Interactions: Focus on Neurotensin (1986) (7)
- Neurotensin Stimulates the Phosphorylation of Caudate Nucleus Synaptosomal Proteins a (1988) (7)
- Sex-related elevation in cortisol during chronic treatment with alprazolam associated with enhanced cognitive performance (2005) (7)
- Gender differences in regional cerebral activity during sadness (2000) (7)
- Personalized Clinical Approaches to Anxiety Disorders. (2020) (6)
- Tolerability of the dexamethasone-corticotropin releasing hormone test in major depressive disorder. (2011) (6)
- The preeminent role of neuropeptide systems in the early pathophysiology of Alzheimer disease: up with corticotropin-releasing factor, down with acetylcholine. (1999) (6)
- Effects of intrahypothalamic injection of quinolinic acid on anterior pituitary hormone secretion in the unanesthetized rat. (1985) (6)
- Investigation of MORC1 DNA methylation as biomarker of early life stress and depressive symptoms. (2020) (6)
- Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder: the effects of antipsychotic treatment (1994) (6)
- Correction to: Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling (2018) (6)
- Early Life Stress Associated With Increased Striatal N-Acetyl-Aspartate: Cerebrospinal Fluid Corticotropin-Releasing Factor Concentrations, Hippocampal Volume, Body Mass, and Behavioral Correlates (2018) (6)
- Increasing public trust and confidence in psychiatric research. (1999) (6)
- The Structure of Personality Disorders within a Depressed Sample: Implications for Personalizing Treatment. (2017) (6)
- The electrophysiological effects of neurotensin on spontaneously active neurons in the nucleus accumbens: An in vivo study (2005) (6)
- Neurotensin effects on calcium/calmodulin-dependent protein phosphorylation in rat neostriatal slices (1991) (6)
- Endocrine associations with health-related quality of life in coronary artery disease patients. (2013) (6)
- Apolipoprotein E epsilon 4. (1994) (6)
- Involvement of non-opioid peptides in the pathogenesis of neurological and psychiatric disorders: evidence from CSF and post-mortem studies. (1985) (6)
- The effects of chronic morphine treatment on neurotensin-induced antinociception (1983) (6)
- In Search of Biomarkers to Guide Interventions in Autism Spectrum Disorder: A Systematic Review. (2022) (6)
- Effects Of Neurotoxic Excitatory Amino Acids On Neuroendocrine Regulation (1983) (6)
- Personalized Medicine and Psychiatry: Dream or Reality? (2013) (5)
- Neuropeptides in cerebrospinal fluid and postmorten brain tissue of schizophrenics, Huntington's choreics, and normal controls (1983) (5)
- Principles of Psychopharmacology for Mental Health Professionals (2006) (5)
- Double Trouble: Treatment Considerations for Patients with Comorbid PTSD and Depression (2020) (5)
- Neuro-transcriptomic signatures for mood disorder morbidity and suicide mortality (2019) (5)
- In the Aftermath of Tragedy: Medical and Psychiatric Consequences (2011) (5)
- Do neuropeptide systems mediate some of the effects of antipsychotic drugs? (1985) (5)
- Larger amygdala volumes after childhood trauma associated with depression and cortisol response to psychosocial stress in adulthood (2012) (5)
- Cytoprotective effect of intracisternally administered neurotensin on cold + restraint-induced gastric ulcers in the rat (1981) (5)
- Chapter 30. Psychostimulants in Psychiatry: Amphetamine, Methylphenidate, and Modafinil (2006) (5)
- Pharmacogenomic testing and antidepressant response: problems and promises (2020) (5)
- Diagnosis and treatment of depression in medical practice. (1993) (5)
- Psychiatric epidemiology. (2012) (5)
- The dexamethasone suppression test and antidepressant response in major depression. (1987) (5)
- Study guide to psychopharmacology : a companion to the American Psychiatric Publishing textbook of psychopharmacology, fourth edition (2009) (5)
- Comorbid postpartum depression and bereavement: a complicated case. (1997) (5)
- Behavioral effects of neurotensin: operant responding and assessment of 'anhedonia'. (1989) (5)
- Screening for Adverse Childhood Experiences. (2020) (4)
- The evaluation and treatment of depression in primary care. (2001) (4)
- 330. Further studies on altered platelet reactivity in major depression (1998) (4)
- Effects of intracisternal neurotensin, β-endorphin or bombesin on ethanol-induced sedation and hypothermia (1980) (4)
- The Search for Treatments for Veterans With Major Depression: Of Paramount Importance, yet Still Elusive. (2018) (4)
- The effects of neurotensin, β-endorphin and bombesin on ethanol-induced behaviors in mice (1983) (4)
- Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide (2018) (4)
- Implications for the practice of psychiatry. (2006) (4)
- Synthesis and biological evaluation of trans-3-phenyl-1-indanamines as potential norepinephrine transporter imaging agents. (2005) (4)
- Chapter 36. Treatment of Childhood and Adolescent Disorders (2006) (4)
- Metabolic syndrome and neurometabolic asymmetry of hippocampus in adult bonnet monkeys (2011) (4)
- ROLE OF THE AUTONOMIC NERVOUS SYSTEM IN NEUROTENSIN'S CYTOPROTECTIVE EFFECT FOR GASTRIC STRESS ULCERS IN RATS (1982) (4)
- State-of-the-Art Prevention and Treatment of PTSD: Pharmacotherapy, Psychotherapy, and Nonpharmacological Somatic Therapies (2016) (4)
- The Holy Grail of Psychiatry (2015) (4)
- Muscimol injections into the median raphe nucleus increase serum ACTH and corticosterone concentrations via a nonserotonergic mechanism (1991) (4)
- Striking a Balance Between Clinical Medical School Departments and the Industry (1997) (4)
- Is decreased imipramine binding by platelet membranes in major depression associated with plasma autoantibodies to imipramine binding sites? (1990) (4)
- Structural Brain Alterations in Polysubstance Abusers (1998) (4)
- The cost effectiveness of therapeutics for Alzheimer’s Disease. (2001) (4)
- Introduction. Norepinephrine: neurotransmitter for the millennium. (2000) (4)
- Reduced left ventricular dimension and function following early life stress: A thrifty phenotype hypothesis engendering risk for mood and anxiety disorders (2017) (4)
- The Ups and Downs of Bipolar Disorder Research (2013) (4)
- A comparison of plasma alprazolam concentrations following different routes of chronic administration in the Sprague-Dawley rat: implications for psychotropic drug research (2000) (4)
- The Physiological Effect of Mental Processes on Major Body Systems (2010) (4)
- The neurobiological consequences of early traumatic experiences: focus on corticotropin-releasing factor (1994) (4)
- PSYCHOPHARMACOLOGY AND THE FUTURE OF PERSONALIZED TREATMENT (2014) (4)
- Design, synthesis and characterization of fluorinated- and iodinated- pyrrolo[2,3-d]pyrimidines as candidates for CRF1 receptor PET/SPECT ligands (1999) (4)
- P.1.233 Effects of paroxetine and venlafaxine-XP on heart rate variability in depression (2003) (4)
- Centrally administered neurotensin inhibits pentobarbital metabolism in mice but not in rats (1987) (4)
- Alterations in Neurotensin‐ and Bombesin‐like Immunoreactivity in MPTP‐Treated Mice a (1988) (4)
- The role of nonopioid peptides in pain. (1987) (4)
- Ziprasidone in the treatment of mania in bipolar disorder (2007) (4)
- P-2-87 Comparison of the safety and tolerance of fluvoxamine and sertraline in depressed outpatients (1995) (4)
- Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position. (2006) (4)
- Contemporary management of depression. Discussion (1994) (4)
- Development and psychometric properties of the sexual and gender minority adverse childhood experiences (SGM-ACEs): Effect on sexual and gender minority adult mental health. (2022) (4)
- Plasma homocysteine and immune activation in patients with malignant melanoma undergoing treatment with IFN-α (2004) (4)
- Child Abuse and Neglect as Risk Factors for Post-Traumatic Stress Disorder (2018) (4)
- Corticotropin-releasing factor is secreted in the BE(2)-C neuroblastoma cell and is responsive to forskolin. (1994) (4)
- Stress and the Impact of Personalized Medicine (2011) (3)
- Brain activation induced by psychological stress in nonpsychotic siblings of patients with schizophrenia (2017) (3)
- Corticotropin-Releasing Factor Type 1 Receptor Antagonism is Ineffective for Women with Posttraumatic Stress Disorder (3)
- The role of norepinephrine in the treatment of depression (1999) (3)
- Preclinical and Clinical Investigations of Corticotropin-Releasing Factor: Assessment of Its Role in Depressive Disorders (1989) (3)
- Corticotropin-Releasing Factor in Depression and Suicide (1988) (3)
- The role of corticotropin-releasing factor in the pathophysiology of depression: Implications for antidepressant mechanisms of action (2008) (3)
- Effects of neurotensin on caudate nucleus protein phosphorylation (1992) (3)
- Neuropeptide Alterations in Depression and Anxiety Disorders (2003) (3)
- Polypharmacology in Psychiatry: Good or Bad? (1998) (3)
- Growth hormone response to growth hormone-releasing factor in depression (1988) (3)
- Treatment Resistance in Personality Disorders (2012) (3)
- EEG Biomarkers for Treatment Response Prediction in Major Depressive Illness. (2019) (3)
- BIOCHEMICAL AND NEUROPEPTIDE ALTERATIONS IN ALZHEIMER'S DISEASE (1992) (3)
- Insular functional alterations in emotional processing of schizophrenia patients revealed by Multivariate Pattern Analysis fMRI. (2020) (3)
- STRESS, CORTICOTROPIN‐RELEASING FACTOR NEURONS, AND THE ACTIONS OF BENZODIAZEPINES (1992) (3)
- Biological Consequences and Transgenerational Impact of Violence and Abuse (2010) (3)
- Dose response relationship between plasma ACTH and cortisol after the infusion of ACTH1–24 (1993) (3)
- Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression. (2022) (3)
- Erratum: Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation (Neuropsychopharmacology (2006) 31, 2505-2513) DOI: 10.1038/sj.npp.1301113 (2006) (3)
- Nootropics (1993) (3)
- Preclinical and clinical evidence for the involvement of corticotropin-releasing factor in the pathogenesis of depression. (1988) (3)
- Subpopulation-specific machine learning prognosis for underrepresented patients with double prioritized bias correction (2021) (3)
- Nootropics (1993) (3)
- Effects of Hypothalamic Peptides on the Central Nervous System (1984) (3)
- Amyloid and Tau in Alzheimer's Disease: Biomarkers or Molecular Targets for Therapy? Are We Shooting the Messenger? (2021) (3)
- Handbook of Physiology: A Critical, Comprehensive Presentation of Physiological Knowledge and Concepts, Section 7: The Endocrine System, vol. IV: Coping With the Environment: Neural and Endocrine Mechanisms (2003) (3)
- Adult glucocorticoid receptor mRNA expression volatility in response to an acute stressor and juvenile CSF corticotropin-releasing factor: A pilot neurodevelopmental study (2017) (3)
- The HPA axis and the pathophysiology of depression: The role of early adverse experience (2000) (3)
- Brain regions mediating neurotensin-induced antinociception (1981) (3)
- Brain Circuitry and Signaling in Psychiatry: Basic Science and Clinical Implications (2004) (3)
- The simultaneous determination of neurotensin and its major fragments by on-line trace enrichment HPLC with electrochemical detection. (1996) (3)
- When Imagination Becomes a Disease: Dealing With Hypochondriacal Patients in Clinical Practice (2019) (3)
- Temporal Stability of Cognitive Functioning and Functional Capacity in Women with Posttraumatic Stress Disorder. (2018) (3)
- Special issue editorial: Personalized medicine in psychiatry in the COVID-19 era: Fighting the impact of the pandemic on mental health (2021) (3)
- Ontogeny of the effect of antipsychotic drug treatment on neurotensin concentrations in the rat brain (1995) (3)
- Screening for depression. (1999) (3)
- Depression in the medically ill (2009) (3)
- Advances in the neuropsychobiology of suicide (2012) (3)
- Neuroendocrinology of Affective Disorders (2009) (3)
- Neuroendocrine Alterations in Major Depressive Disorder (2020) (3)
- Depression in cancer patients. Diagnostic and treatment considerations. (1988) (3)
- Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression. (2021) (3)
- Chapter 103 – Depression (2015) (3)
- Going beyond risk factor: Childhood maltreatment and associated modifiable targets to improve life-long outcomes in mood disorders (2022) (3)
- Adaptation to cold antagonizes neurotensin-induced hypothermia in mice (1986) (3)
- Inhibition of neurotensin-induced antinociception in morphine tolerant mice (1981) (3)
- Striking a Balance With the Pharmaceutical Industry: Part II (1997) (2)
- Erratum: The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment (Archives of General Psychiatry (1998) vol. 55 (580-592)) (2005) (2)
- Effects of zoloft® on platelet/endothelial biomarkers in depressed patients after acute coronary events: Sertraline Anti-Depressant Heart Attack Randomized Trial (SADHART platelet substudy) (2002) (2)
- Syndrome of inappropriate antidiuretic hormone secretion. (1992) (2)
- The Escalating Pharmaceutical Company Wars: Where is an Academic to Hide? (1998) (2)
- Effects of Acute and Subchronic Administration of Typical and Atypical Antipsychotic Drugs on the Neurotensin System of the Rat Brain 1 (2000) (2)
- APOLIPOPROTEIN E EPSILON 4. AUTHORS' REPLY (1994) (2)
- The Neural Correlates of Social Anxiety Disorder and Response to Pharmacotherapy (2006) (2)
- Effects of haloperidol, quinelorane, and lithium on regional neurotensin/neuromedin N concentrations: Further evidence for neurotensin/neuromedin N‐Dopamine interactions (1994) (2)
- Two-year placebo-controlled maintenance study to assess recurrence prevention with venlafaxine XR in patients with recurrent unipolar major depression (2007) (2)
- Prevalence of Depression and Anxiety in CABG Patients (2003) (2)
- The Role of the Hypothalamic–Pituitary–Adrenal Axis in Anxiety Disorders (2015) (2)
- Measurement invariance of the Childhood Trauma Questionnaire by gender, poverty level, and HIV status. (2018) (2)
- Putative biological predictors of treatment response in bipolar disorders (2017) (2)
- Trauma and depression (2006) (2)
- Thyrotropin releasing hormone (TRH): potentiation of the anticonvulsant properties of phenobarbital sodium (1975) (2)
- Basics of Psychopharmacology (2005) (2)
- Neurotensin Alters Phosphorylation of Neostriatal Proteins a (1987) (2)
- Substance Use Disorders (2005) (2)
- Treatment-Resistant Obsessive-Compulsive Disorder (2012) (2)
- Contemporary issues in the management of depression: Introduction (1994) (2)
- THE ROLE OF NEUROPEPTIDES IN THE PATHOPHYSIOLOGY OF AFFECTIVE DISORDERS (1992) (2)
- Evidence for a role for corticotropin-releasing factor in the pathogenesis of anxiety disorders and in the action of triazolobenzodiazepines (1990) (2)
- Cocaine Effects on Central Nervous System Neurotensin Concentrations a (1992) (2)
- Neurotensin-sensitive protein phosphorylation in the rodent caudate nucleus (1991) (2)
- Effects of Vortioxetine Versus Placebo on Cognition and Functional Capacity in Adults With Posttraumatic Stress Disorder. (2021) (2)
- Transcription Factor Motifs Associated with Anterior Insula Gene Expression Underlying Mood Disorder Phenotypes (2019) (2)
- Triiodothyronine accelerates and enhances the antipsychotic effect of risperidone in acute schizophrenia. (2016) (2)
- Further Evidence of Dopamine's Role in Depression (1997) (2)
- Clinical Aspects of Neuropeptide Research (1990) (2)
- The rational use of narcotic analgesics, benzodiazepines and psychostimulants in medical practice. A response to the paper "Prescribing addictive medication". (1990) (2)
- 96-2 The extracellular metabolism of corticotropin-releasing factor: A potential new target for neuropsychopharmacologic interventions (1997) (2)
- Elevated levels of central stress mediators in irritable bowel syndrome (2003) (2)
- Corticotropin-Releasing Factor Circuitry in the Brain – Relevance for Affective Disorders and Anxiety (2007) (2)
- 228. Transcriptome-Wide Analysis Identifies ICAM5 Differentially Expressed in Chronic PTSD Symptoms Versus Resiliency Post Trauma Exposure in a Longitudinal Study (2018) (2)
- Chapter 4. Peptides in the Central Nervous System: Focus on Thyrotropin Releasing Hormone and Neurotensin (1982) (2)
- Psychobiology and psychopharmacology: issues in clinical research training. (1986) (2)
- New perspectives on the neurobiology of schizophrenia and the role of atypical antipsychotics: introduction (2001) (2)
- Peptides and Psychiatry (2001) (2)
- Acute and six-month depression-related abnormalities in the sleep-wake rhythm of cardiac autonomic activity in survivors of acute coronary syndromes (2017) (2)
- S.14.05 Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia (2003) (2)
- Nicotine Dependence and Its Treatment (2010) (2)
- Depression in Patients with Congestive Heart Failure (2003) (2)
- Affective State (2020) (2)
- The Role of Dopamine in the Pathophysiology and Treatment of Major Depressive Disorder (2010) (2)
- Efficacy of Vortioxetine Monotherapy for Posttraumatic Stress Disorder (2021) (2)
- The effects of acute antipsychotic drug administration on the neurotensin system of the developing rat brain. (2000) (2)
- Precision psychiatry: Personalized clinical approach to depression (2018) (2)
- TOPOGRAPHY AND FUNCTIONAL IMPLICATIONS OF NEUROTENSIN‐CONTAINING STRUCTURES IN THE RAT BRAIN (1982) (2)
- Loss and Deprivation: From Animal Models to Clinical Presentation (2005) (2)
- Intra‐Accinnbens Injection of Neurotensin Antagonizes the Behavioral Supersensitivity to L‐DOPA in Dopamine‐Denervated Rats a (1988) (2)
- A Generalized Predictive Algorithm of Posttraumatic Stress Development Following Emergency Department Admission Using Biological Markers Routinely Collected from Electronic Medical Records (2020) (2)
- Pharmacokinetics of growth hormone secretion in humans induced by growth hormone releasing hormone. (1990) (2)
- Formulary considerations for treating psychiatric disorders: Schizophrenia (1997) (1)
- Neurobiology of Mood Disorders (2018) (1)
- INCENTIVE BIAS ? AUTHORS' REPLY (1996) (1)
- Calcium‐, calcium/calmodulin‐, and calcium/phospholipid‐stimulated protein phosphorylation in the rat anterior pituitary (1992) (1)
- Marked reduction in serotonergic activity in a sexually aggressive adolescent male. (2014) (1)
- Plasma homocysteine and immune activation in patients with malignant melanoma undergoing treatment with IFN-alpha. (2004) (1)
- Introduction: Fifty Years of Lithium Use in the Treatment of Bipolar Disorder (2000) (1)
- Role of Serotonininthe Pathophysiologyof Depression : Focuson the Serotonin Transporter (2004) (1)
- Aerobic exercise in the treatment of PTSD: An examination of preclinical and clinical laboratory findings, potential mechanisms, clinical implications, and future directions. (2023) (1)
- P.2.a.018 Interaction of pimpamperone, citalopram and genetic variables in the prediction of antidepressant response (2011) (1)
- Animal Models for Post-Traumatic Stress Disorder (2018) (1)
- Stress Neurobiology and Corticotropin-Releasing Factor (2006) (1)
- 549. DNA Methylation Biomarkers and Treatment Effects of a Corticotropin Releasing Hormone Type 1 Receptor Antagonist in a Biologically-Defined Subset of PTSD-Patients (2017) (1)
- Atomoxetine: A New Treatment for ADHD (2002) (1)
- Erratum: From clinical research to clinical practice: A 4-year review of ziprasidone (CNS Spectrums (2005) 10, 11 suppl 17 (1-19)) (2005) (1)
- Psychedelics and Psychedelic-Assisted Psychotherapy. (2021) (1)
- Inflammation and psychiatric disorders (2015) (1)
- Placebo-controlled trial of the efficacy and tolerability of venlafaxine and fluoxetine in outpatients with major depression (1998) (1)
- Technology and Mental Health: State of the Art for Assessment and Treatment. (2022) (1)
- Hypothalamic-pituitary-thyroid axis abnormalities, major depression, and treatment response (2000) (1)
- Improvement in general life functioning with venlafaxine versus fluoxetine in outpatients with major depression (2002) (1)
- Risk for adult posttraumatic stress disorder is predicted by child abuse and FKBP5, a gene regulating stress-responsiveness (2008) (1)
- Depression and cardiovascular disease: Increasing evidence of a connection (1998) (1)
- S-29-3 Stress peptides and HPA axis reactivity in depression (1995) (1)
- The Pharmacokinetics of Venlafaxine (1995) (1)
- The Biology of Late-Life Depression (1993) (1)
- A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression (2021) (1)
- Child abuse and neglect (2020) (1)
- Synthesis and biological evaluation of 2β,3α-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents (2007) (1)
- Chapter 1. Tricyclic and Tetracyclic Drugs (2006) (1)
- Improvement in social activity level, general life and cognitive functioning with venlafaxine versus fluoxetine in inpatients with melancholic depression (2002) (1)
- Introduction. The Phenomenology and Treatment of Aggression Across Psychiatric Illnesses (1999) (1)
- Pharmaco-behavioral effects of oligopeptides endogenous to brain. (1978) (1)
- Validity and severity thresholds for the depression subscale of the Affective Self Rating Scale: an equipercentile equating study using classical test theory. (2021) (1)
- Design, synthesis and evaluation of amino-anilino-pyramidines as potential spect ligands for the CRF1 receptor (2000) (1)
- S.05.01 Overview of CRF in psychiatric diseases (1997) (1)
- Novel Pharmacologic Treatment of Stress and Addiction (2007) (1)
- Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling (2015) (1)
- Biological Effects of Depression in Cardiac Illness (2018) (1)
- The National Bioethics Advisory Commission and Its Report (1998) (1)
- Allelic Variation of the Serotonin Transporter Gene Promoter (1996) (1)
- A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability. (2022) (1)
- Individual cognitive and depressive traits associated with maternal versus paternal family history of Late-onset Alzheimer’s disease: Proactive semantic interference versus standard neuropsychological assessments (2018) (1)
- The Trifecta of Misery and Disease Vulnerability: Poverty, Childhood Maltreatment, and Inflammation. (2021) (1)
- Chapter 12. Duloxetine and Milnacipran (2006) (1)
- Failure to Recover from Proactive Semantic Interference Differentiates Amnestic Mild Cognitive Impairment and PreMCI from Normal Aging after Adjusting for Initial Learning Ability (2018) (1)
- SASOP Biological Psychiatry Congress 2013 Abstracts (2013) (1)
- 28-4 Biological markers of major depression: Are we any closer? (1997) (1)
- Stress, Hypothalamic-Pituitary-Adrenal Function, and Aging: Focus on Corticotropin-Releasing Factor (1990) (1)
- Lack of effect of a behaviorally active dose of cholecystokinin octapeptide upon aromatic amino acid levels in plasma and brain (1980) (1)
- Recent Findings in the Pathophysiology of (2008) (1)
- Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography. (2003) (1)
- Pharmacogenomic Tests in Psychiatry: Not Ready for Prime Time (2019) (1)
- Placebo in the Evaluation of Psychiatric Treatments (1998) (1)
- Alterations in nociception and body temperature after intracisternal administration of neurotensin , 3-endorphin , other endogenous peptides , and morphine ( peptide-induced analgesia / thermoregulation ) (1)
- Stress and depression: from vulnerability to treatment (2000) (1)
- The Neurobiological Basis of Posttraumatic Stress Disorder and Its Treatment Priyattam J. Shiromani Terence M. Keane Joseph E. LeDoux Post-Traumatic Stress Disorder: Basic Science and Clinical Practice 2009 Humana Press 409 pp $89.95, hardcover (2009) (1)
- Treatment-Resistant Posttraumatic Stress Disorder (2012) (1)
- Temporary alteration in blood brain barrier permeability to plasma proteins during monosodium L glutamate induced seizures (1974) (1)
- Distribution of Peptides in the Central Nervous System (1984) (1)
- Chromosome 22q and the mind–brain interface (2001) (1)
- Overcoming Underrepresentation in Clinical Datasets for Accurate Subpopulation-specific Prognosis (2021) (1)
- Bipolar disorder: A syndrome in evolution (2004) (1)
- Chapter 35. Management of Noncognitive Symptoms of Dementia (2006) (1)
- More than one‐half of a decade of experience with venlafaxine dual serotonin‐norepinephrine reuptake inhibitor (2000) (1)
- Corticotrophin- releasing factor, beta-endorphin and somatostatin depressed patients treated with electroconvulsive therapy. Neuropeptide concentrations in the cerebrospinal fluid of (2011) (1)
- Understanding Posttraumatic Stress Disorder: From Diagnosis and Neurobiology to Treatment (2016) (1)
- Alterations in Platelet [3H]-Imipramine Binding, 5HT Uptake and Plasma α1-acid Glycoprotein Concentrations in Patients with Major Depression (1991) (1)
- Alterations in CSF concentrations of somatostatinlike immunoreactivity in chronic pain patients (1987) (1)
- P.2.c.019 Two-year maintenance treatment study assessing recurrence prevention with venlafaxine XR in patients with recurrent unipolar major depression (2006) (1)
- Specific Associations Between Type of Childhood Abuse and Elevated C-Reactive Protein in Young Adult Psychiatric Rehabilitation Participants (2022) (1)
- Teaching Neurobiology in Psychiatry (2019) (1)
- Cyclic AMP‐dependent protein phosphorylation in the rat anterior pituitary (1990) (1)
- Attention Deficit Hyperactivity Disorders: Animal Models (2014) (1)
- CHAPTER 11:Modulation of HPA Axis Function for Treatment of Mood Disorders (2012) (1)
- 4.61 Steroid-Induced Psychosis in the Pediatric Population: A New Case and Review of the Literature (2017) (1)
- Adrenal Gland Enlargement in Major Depression-Reply (1993) (1)
- Genetic Variation in Corticotropin Releasing Hormone Binding Protein predicts antidepressant outcomes (2018) (1)
- Growth and endocrine alterations after neonatal monosodium L glutamate in the rat: evaluation of relationship to arcuate dopamine neuron damage (1975) (1)
- Diurnal variation of heart rate variability as a physiological index of mood and emotion regulation processes in Major Depression and Borderline Personality Disorder (2020) (1)
- Further Evidence for Neurotensin-Dopamine Interactions in the Central Nervous System (1988) (1)
- Affective disorders: depression and mania (2006) (1)
- Treatment-Resistant Social Anxiety Disorder (2012) (1)
- Systematic Approach to Treatment-Resistant Depression (2012) (1)
- Rhythmicity and response to a.m. and p.m. CRH challenge in elderly subjects (1993) (1)
- 212. Suicidal Ideation and Behavior in Institutions of Higher Learning: Categorizing Levels of Risk (2017) (1)
- Platelet Thromboxane A2 Secretion in Patients With Major Depression Responsive to Electroconvulsive Therapy (2008) (1)
- Psychoendocrine Aspects of Depression1 (1980) (1)
- Release of Corticotropin‐releasing Factor from Rat Brain in Vitro (1986) (1)
- Chapter 34. Treatment of Anxiety Disorders (2006) (1)
- Neurotensin: Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone. Progress in antistochemistry and cytochemistry, vol. 16. Manfred Reinecke. 1985, 175 pages (1986) (1)
- Fifty years of lithium use in the treatment of bipolar disorder (2000) (1)
- Biological Distinction Between Unipolar and Bipolar Disorder (2003) (1)
- CONTINUING DIALOGUE ON INCENTIVE BIAS. AUTHOR'S REPLY (1997) (1)
- The Development of New Technologies in Medicine: What Will the Impact Be in Psychiatry? (2001) (1)
- Genetic factors in stress and major depression (2009) (1)
- Paroxetine in breast milk [3] (multiple letters) (2001) (1)
- The relationship between substance use, prior trauma history, and risk of developing post-traumatic stress disorder in the immediate aftermath of civilian trauma. (2021) (1)
- Valproate for Behavioral Agitation in Elderly Patients with Dementia (1995) (0)
- Chapter 41. Psychiatric Emergencies (2006) (0)
- Taming the black dog (1999) (0)
- Reply (2009) (0)
- 2013 Daniel H. Efron Research Award (2012) (0)
- Platelet Reactivity, Psychological Stress, and CHD (1997) (0)
- Bipolar Disorder (2019) (0)
- The Neurobiology of Depression The search for biological underpinnings of depression is intensifying. Emerging findings promise to yield better therapies for a disorder that too often proves fatal (1998) (0)
- Erratum to “Behavioral effects of the CRF1 receptor antagonist R121919 in rats selectively bred for high and low activity in the swim test” [Psychoneuroendocrinology 33(8) (2008) 1093–1101] (2009) (0)
- A new psychobiological theory of attachment: Primum non nocere (1992) (0)
- Drug Interactions: Valproate and Lorazepam (1997) (0)
- Childhood maltreatment, prefrontal-paralimbic gray matter volume, and substance use in young adults and interactions with risk for bipolar disorder (2021) (0)
- Endocrine Disorders (2018) (0)
- Trial registration : Clinicaltrials . gov Identifier : NCT 00360399 . Registered 02 AUG 2006 . First patient randomized 09 FEB 2007 (0)
- Cardiac arrest and cardiopulmonary resuscitation increases CRF R1 receptor binding (2006) (0)
- Do CSF concentrations of somatostatin change with pain clinic therapy in chronic low back pain patients? (1990) (0)
- Chapter 44. Treatment of Insomnia (2006) (0)
- Treatment-Refractory Depression: The Role of Buspirone Augmentation (2001) (0)
- Cuba: A Land Stuck in Time (2000) (0)
- Chapter 6. Citalopram and S-Citalopram (2006) (0)
- MDMA May Be Neurotoxic to Dopamine Neurons (2002) (0)
- The Adrenal Gland and Depression-Reply (1993) (0)
- A Potential New Therapy for TCA Toxicity (1998) (0)
- Activities of Daily Living (2021) (0)
- Stress-Induced Cortisol Secretion Affects Memory in the Elderly (1997) (0)
- Reply to Letter to the Editor "Continuing Dialogue on Incentive Bias" (1997) (0)
- PATHOPHYSIOLOGY OF MOOD DISORDERS: NEUROENDOCRINE MECHANISMS (2013) (0)
- Migraine and affective disorders (1996) (0)
- Transcranial Magnetic Stimulation for Refractory Depression (1996) (0)
- PREFACE (1982) (0)
- What can we learn from CSF studies: The CRF database (1998) (0)
- Preface (1992) (0)
- Non-peptide ligands acting at CRF receptors as novel anxiolytics or antidepressants (2008) (0)
- Hypercortisolemia Predicts Memory Deficits in Elderly (1998) (0)
- Chapter 27. Lamotrigine (2006) (0)
- Ellen Stover (2014) (0)
- MOLECULAR BIOLOGY OF STRESS Sponsored by: The Director's Sponsors Fund (1988) (0)
- Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy. (2023) (0)
- HPA Axis Dysfunction, Hydrocortisone Treatment, and Chronic Fatigue Syndrome (2001) (0)
- Chapter 16. Clozapine (2006) (0)
- In Memoriam-Dwight L. Evans, MD, MS (2023) (0)
- Managed Care in Psychiatry: Panacea or Pariah? (1997) (0)
- A Diagnostic Test for Alzheimer's in Cerebrospinal Fluid (1998) (0)
- Enhanced psychosocial stress-induced IL-6 responses are associated with attenuated stress-induced cortisol responses in patients with major depression and increased early life stress (2006) (0)
- A Potential Role for D4 Dopamine Receptors in Schizophrenia (1995) (0)
- Serotonin Antagonists as Antipsychotics (1993) (0)
- Can Calcium Supplementation Prevent Postpartum Depression (2001) (0)
- 345 Depression during IFN-ALFA plus ribavirin therapy: prevalence and prediction (2003) (0)
- Paroxetine Is Effective for Bipolar Depression (1996) (0)
- The Neurobiology ofAnxiety Disorders : BrainImaging , Genetics , andPsychoneuroendocrinology (2010) (0)
- Apolipoprotein E4 In Late Onset Depression (1994) (0)
- Suicidal Ideation in Primary Care Patients with Panic (2002) (0)
- Autoimmune Thyroid Disease and Depression (1999) (0)
- The Role of Signal Transduction Systems in the Pathophysiology and Treatment of Bipolar Disorder (2015) (0)
- Somatostatin Immunoreactivity in Postmortem Brain From Depressed Suicides-Reply (1988) (0)
- Suppression and Its Neural Substrates (2004) (0)
- Introduction Advances in the Treatment of Mood and Anxiety Disorders (2004) (0)
- Neurotransmitter regulation of CRF secretion in vitro (2018) (0)
- Further Evidence of Endocrine Consequences of Human Pheromones (1998) (0)
- S.15.04 Identification and treatment of postpartum depression (1997) (0)
- Author ' s response to reviews Title : Personalized medicine in psychiatry : problems and promises (2013) (0)
- Chapter 10. Mirtazapine (2006) (0)
- Ultrastructural Changes in the Striatum of Schizophrenics (1998) (0)
- Lithium Dosing for Manic Depressive Disorder (1996) (0)
- CNS volume 1 issue 2 Cover and Front matter (1996) (0)
- Adverse Life Events in Adolescence Predicts Adult Depression (2002) (0)
- Evidence for Therapeutic Effects of NSAIDs in Alzheimer's Disease (2000) (0)
- Stress, Hormones, and Aging (2000) (0)
- Introduction - Developmental neurobiology and psychiatry: Challenges and best practices for studies in children and adolescents (2005) (0)
- The Importance of Longitudinal Studies in Psychiatric Disorders (1998) (0)
- Response to Zhang and Ho: Addressing Ketamine's Use in Depression. (2016) (0)
- Mechanisms of neuropeptide actions on behavior (1986) (0)
- Management of Treatment-Resistant Insomnia (2012) (0)
- New Type of Globin Discovered in the Human Brain (2000) (0)
- A validated predictive algorithm of post-traumatic stress course following emergency department admission after a traumatic stressor (2020) (0)
- In memoriam—Stephen Hugh Koslow, Ph.D (2021) (0)
- Chapter 11. Venlafaxine (2006) (0)
- Managing depression : new perspectives (1994) (0)
- Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation (2006) (0)
- Psychedelics and Psychedelic-Assisted Psychotherapy: Clinical Implications (2020) (0)
- Signal Transduction Abnormalities in Patients with Mood Disorders (1999) (0)
- Chapter 26. Gabapentin (2006) (0)
- Chapter 43. Psychopharmacology During Pregnancy and Lactation (2006) (0)
- Paroxetine for Depression in AIDS Patients (1998) (0)
- Practical Management of Bipolar Disorder: Pharmacological treatment of bipolar depression (2010) (0)
- Dopamine D4 Receptors and Schizophrenia: An Unhappy Ending? (1997) (0)
- Chapter 18. Quetiapine (2006) (0)
- Childhood adversity modulation of central autonomic network components during cognitive regulation of emotion in major depressive disorder and borderline personality disorder. (2021) (0)
- Chapter 33. Treatment of Schizophrenia (2006) (0)
- Venlafaxine vs fluoxetine, fluvoxamine and paroxetine: Onset of antidepressant action in patients with recurrent depression (2002) (0)
- Depression Must be Invisible (1997) (0)
- Subject Index Vol. 52, 1990 (1990) (0)
- Symptoms Vs Syndromes in the Treatment of Psychiatric Disorders (1998) (0)
- P-5-2 Behavioral, monoaminergic, neuroendecrine and neuropeptidergic alterations in grown nonhuman primates exposed to unpredictable early rearing: relevance to human anxiety (1995) (0)
- Dopamine Transporter Density Reduced in Psychostimulant Users (1999) (0)
- Pattern of expression in different stages of schizophrenia : comparing induced pluripotent stem cell-derived neurons with post mortem cerebral cortex (2015) (0)
- Reply (2000) (0)
- Buspirone May Reverse SSRI-Induced Male Sexual Dysfunction (1995) (0)
- A Concise Guide to Understanding Suicide: Antidepressants (2014) (0)
- 265. The HPA axis and the pathophysiology of depression: The role of early adverse (1998) (0)
- Chapter 19. Aripiprazole (2006) (0)
- Further Evidence for Brain Abnormalities in Methamphetamine Abusers (2004) (0)
- Increased Pituitary Gland Size and Adolescent Depression (2004) (0)
- Chapter 22. Drugs to Treat Extrapyramidal Side Effects (2006) (0)
- #38 Immune, neuroendocrine, and behavioral response to interferon α in rhesus monkeys: A potential role for CRF (2005) (0)
- Susceptibility Locus for Familial Schizophreniaon Chromosome 1 (2000) (0)
- PL10 The Neurobiology of Child Abuse: Treatment Implications (2011) (0)
- A SERT Polymorphism Contributes to Life-Stress-Induced Depression (2003) (0)
- More on Hypothalamic-Pituitary-Thyroid Axis Abnormalities in Depressed Patients (2001) (0)
- Recurrence prevention in patients with recurrent major depression receiving 12 months of treatment with venlafaxine XR (2007) (0)
- Neuroendocrinological Research in Psychiatry (2002) (0)
- Alterations in Neuropeptide Systems in Alzheimer’s Disease (1990) (0)
- Chapter 31. Treatment of Depression (2006) (0)
- 69-1 Animal models of maternal separation: Evidence for persistent neurochemical effects (1997) (0)
- Serotonin antagonists as antipsychotic drugs (1992) (0)
- Bipolar Disorders (2000) (0)
- A 47-year-old woman with physical symptoms of depression (2004) (0)
- NREM Sleep (0)
- Dr. Nemeroff and Associates Reply (1986) (0)
- Preface (1988) (0)
- NREM Sleep (0)
- 210. CRF1 receptor antagonists as novel putative antidepressants and anxiolytics (2000) (0)
- SEMANTIC INTERFERENCE DEFICITS AND THEIR RELATIONSHIP WITH SLEEP-WAKE PHENOTYPES IN ASYMPTOMATIC OFFSPRING OF LATE-ONSET ALZHEIMER’S AND ACUTE DISEASE PATIENTS (2017) (0)
- Abnormalities in corticotropin-releasing factor (CRF) in neurodegenerative diseases (2018) (0)
- Erratum to: The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases (2012) (0)
- Prefrontal Neuronal Activity and Striatal Dopamine Function in Schizophrenic Patients (2002) (0)
- 275. The role of academia in working with the pharmaceutical industry (1998) (0)
- Pretreatment with the antidepressant, paroxetine, attenuates development of sickness behavior during high dose interferon alpha therapy (2000) (0)
- Dr. Heim and Colleagues Reply (2002) (0)
- A POTENTIAL ROLE FOR NEUROTENSIN IN MEDIATING THE THERAPEUTIC EFFECTS OF ANTIPSYCHOTIC DRUGS (1992) (0)
- Procede et dispositif d'administration transdermique du lithium (1998) (0)
- Epigenetic Modification as Mediator of Gene-Childhood Trauma Interactions (2013) (0)
- Chapter 12 Psychiatric Manifestations of COVID-19 (0)
- List of contributors (2020) (0)
- #107 Indicators of innate immune system activity in humans increase with psychosocial stressor challenge: Major depressives vs. non-depressives (2005) (0)
- Introducing the Point-Counterpoint Series (2006) (0)
- [26] Immunological, pharmacological, and electrophysiological detection of T-cell-modulating properties of substances of abuse (1995) (0)
- Chapter 7. Monoamine Oxidase Inhibitors (2006) (0)
- Cortisol Response to Norepinephrine Reuptake Blockade in Subclinical Depression (2001) (0)
- Management of Treatment-Resistant Substance and Alcohol Abuse (2012) (0)
- Challenges in Assessment of Daytime Sleepiness in Cognitively Impaired Populations Can Be Bypassed Through Use of Ecological Momentary Assessment (2020) (0)
- Carbamazepine Reduces Cocaine Craving (1997) (0)
- Chapter 28. Topiramate (2006) (0)
- HORMONES IN THE TREATMENT OF NERVOUS AND MENTAL DISEASE: PRESENT STATUS AND DEVELOPMENT (1978) (0)
- Polycystic Ovary Syndrome, Psychiatric Morbidity, and Quality of Life (2004) (0)
- Introduction/Lithium in the Treatment of Manic-Depressive Illness: An Update (1998) (0)
- Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents. (2007) (0)
- A 32-year-old male with suicide attempt (2004) (0)
- Preclinical evaluation of the putative antidepressant nefazodone (1993) (0)
- Special Report: Management of Major Depression: Yesterday, Today, and Tomorrow (2021) (0)
- The hypothalamic-pituitary-adrenocortical system (1997) (0)
- Pharmacotherapeutic considerations for psychiatric disorders: Depression (1997) (0)
- Pituitary-adrenal responsiveness of adult survivors of childhood abuse in the CRF stimulation test (2000) (0)
- 688. The CRH-1 Receptor Antagonist Saga in Mood and Anxiety Disorders: The Good, the Bad and the Ugly (2017) (0)
- More on Dopaminergic Hypoactivity in Depressed Suicide Victims (2001) (0)
- More on Thyroid Function in Depressed Patients (1998) (0)
- Chapter 23. Lithium (2006) (0)
- One Brain, But Different Clinical Disciplines: Should Psychiatry and Neurology Be United? (2000) (0)
- Anorexia and Bulimia Nervosa (2012) (0)
- Treating Major Depression in Alzheimer's Disease (1997) (0)
- 253. Platelet activation in treatment responders vs. nonresponders in patients with major depression (2000) (0)
- Decreased Serotonin Uptake Sites in PTSD: Relation to Clinical Features (1995) (0)
- Psychiatric Morbidity in Adults Treated with Growth Hormone (1996) (0)
- Clozapine Improves Cognitive Function in Refractory Schizophrenics (1997) (0)
- IN MEMORIAM-Stephen Hugh Koslow, Ph.D (2021) (0)
- More on Depressed Patients with Subtle Hypothyroidism (1999) (0)
- Chapter 14. Buspirone (2006) (0)
- Chapter 24. Valproate (2006) (0)
- Posttraumatic stress disorder: Recent advances in basic science and clinical research (1989) (0)
- Leptin Receptor Gene Linked with Obesity and Pituitary Dysfunction (1998) (0)
- Predictors of Time to Recovery from Depression in Women (1997) (0)
- Chapter 8. Trazodone and Nefazodone (2006) (0)
- Ecstasy Alters Immune Function in Humans (2002) (0)
- Molecular neuropharmacology for the new millennium (2002) (0)
- Overexpression oftheHighAffinity Choline Transporter inCortical Regions Affected byAlzheimer's Disease Evidence fromRapidAutopsyStudies (1994) (0)
- C.11.02 Severe depression – how to diagnose and treat? (2008) (0)
- Subject Index Vol. 50, 1989 (1989) (0)
- Selegiline for Social Phobia (1998) (0)
- Preventing Post-Stroke Depression with Sertraline Prophylaxis (2003) (0)
- Further Study Warranted to Evaluate TNFα and IFNγ as Biomarkers for PTSD Risk: Response to Na. (2020) (0)
- S-26-5 Psychopharmacology of pregnant and postpartum women (1996) (0)
- Effects of sigma receptor blockade on regional brain neurotensin concentrations (1990) (0)
- 159. History of childhood trauma is associated with impaired glucocorticoid sensitivity in adulthood (2011) (0)
- Comprar The American Psychiatric Publishing Textbook of Psychopharmacology | Jacob Ballon | 9781585623099 | American Psychiatric Publishing (2009) (0)
- Further Evidence of Olanzapine-Associated Diabetes (2002) (0)
- Assessment and Management of Treatment Resistance in Panic Disorder (2012) (0)
- Too Much Stuff, Too Little Time (1997) (0)
- Depression, Heart Disease: A Curiously Strong Relationship (2008) (0)
- More on Childhood Adversity and Vulnerability to Depression (2002) (0)
- Fluoxetine for Adolescent Refractory Depression (1995) (0)
- Short communication The BE (2)-M17 neuroblastoma cell line synthesizes and secretes corticotropin-releasing factor (1994) (0)
- 344 Depressive symptoms during IFN-alpha/ribavirin therapy are associated with reduced viral clearance in patients with hepatitis C (2003) (0)
- Editorial (0)
- 168. Trichotillomania: A controlled trial of venlafaxine (1998) (0)
- Gender Differences in the Brain's Functional Organization for Language (1995) (0)
- Blockade of Substance P Receptors Produces Antidepressant Effects (1998) (0)
- P.1.a.003 Epigenetic regulation at the FKBP5 genetic locus by age and depressive phenotypes: implications for age-related disease (2014) (0)
- A 26-year-old man with unremitting depression (2003) (0)
- EFFECTS OF PAROXETINE ON CYTOKINE RELEASE AND DEPRESSION INDUCED BY INTERFERON ALFA-2B (1999) (0)
- Establishing a training plan and estimating inter-rater reliability across the multi-site Texas childhood trauma research network (2023) (0)
- 18F-Labeled analogs of reboxetine as PET imaging agents for norepinephrine transporters (2007) (0)
- Neural Reactivity to Negatively Valenced Stimuli in Young Adults With Bipolar Disorder and a History of Bullying Victimization (2020) (0)
- Paroxetine plus Antipsychotics for Psychotic Depression (1995) (0)
- Method and apparatus for the transdermal administration of lithium (1998) (0)
- 252. Platelet activation of depressed patients in comparison to patients with aortic atherosclerosis (2000) (0)
- Fluvoxamine vs. Maprotiline for Negative Schizophrenic Symptoms (1998) (0)
- Effect of chronic treatment with thyrotropin-releasing hormone (TRH) or an analog of TRH (linear beta-alanine TRH) on the hypothalamic-pituitary-thyroid axis. (1980) (0)
- Molecular mechanisms regulating behavior: Focus on genetic and environmental influences (2006) (0)
- Chapter 17. Olanzapine (2006) (0)
- Efficacy of Pregabalin in Social Anxiety Disorder (2004) (0)
- Suicide and Inflammation. (2023) (0)
- How Universal Is Postpartum Depression (1996) (0)
- How Will We Solve the Critical Shortage of Clinician–Scientists in Psychiatry? (2001) (0)
- Author ’ s Accepted Manuscript Amygdala reactivity and anterior cingulate habituation predict PTSD symptom maintenance after acute civilian traumaAmygdala predicts PTSD symptom maintenance (2016) (0)
- Childhood Parental Loss Associated with Alcoholism in Women (1996) (0)
- A Major Step Backward for the American Medical Association (1999) (0)
- PART TWO OF A TWO-PART SERIES : FORMULARY CONSIDERATIONS FOR TREATING PSYCHIATRIC DISORDERS : SCHIZOPHRENIA (1997) (0)
- MRI detection of abnormality in the corpus callosum and late-onset depression (1993) (0)
- Chapter 2. Fluoxetine (2006) (0)
- Recent Advances in the Neurochemical Modulation of Behavior: Focus on Depression and Alzheimer’s Disease (1989) (0)
- Cognitive Function and Atypical Antipsychotics (2004) (0)
- A Biological Component to Transsexuality (1996) (0)
- Book Forum (1994) (0)
- Effects of Tryptophan Depletion on Aggression in Men (2000) (0)
- Smoking (Tobacco), PTSD and depression (2016) (0)
- Cuba II: A Land Stuck in Time (2000) (0)
- Cultural Effects on Brain Function: A PET Study (2000) (0)
- The Emerging and Disheartening Picture of the Consequences of Child Abuse and Neglect: Implications for Psychiatric Morbidity (1997) (0)
- The Rage to Know, the Rage to Teach, and the Rage to Heal: What Is the Proper Balance? (2001) (0)
- Editorial Board (2007) (0)
- Introduction Looking to the future : how can research prevent suicide ? (2015) (0)
- Chapter 39. Treatment of Agitation and Aggression in the Elderly (2006) (0)
- Affective disease and peptides (1993) (0)
- How Rare Is "Pure" Generalized Anxiety Disorder? (2002) (0)
- Do Sexually Abused Girls Grow Up to Become Suicidal Older Women (2004) (0)
- Identification of a signalling mechanism by which the microbiome regulates Th17 cell-mediated depressive-like behaviors in mice (2020) (0)
- Management of Treatment-Resistant Major Psychiatric (2014) (0)
- Chapter 40. Treatment of Personality Disorders (2006) (0)
- Serotonin Stimulation and Platelet Calcium Uptake in Depressed Patients (2000) (0)
- NEURO~NSIN-SENS~IVE FROT~IN PHOSPH~R~A~ON IN THE RODENT CAUDATE NUCLEUS' (1991) (0)
- PART ONE OF A TWO-PART SERIES : PHARMACOTHERAPEUTIC CONSIDERATIONS FOR PSYCHIATRIC DISORDERS : DEPRESSION (1997) (0)
- Chapter 42. Treatment During Late Life (2006) (0)
- Corticotropin Releasing Factor, the Amygdaloid Complex, and Depression: A Hypothetical Interrelationship (1990) (0)
- More on Hypocretin in Narcolepsy (2000) (0)
- Chapter 38. Treatment of Eating Disorders (2006) (0)
- A commentary on methods in peptide neurobiology: focus on neurotensin. (1992) (0)
- Adverse Effects of Lithium on the Thyroid Gland: A Radiology Study (2002) (0)
- The Latest on Treatment-Resistant Depression (2015) (0)
- Abnormal Growth Hormone Secretion in Depression Confirmed (1998) (0)
- Management of Treatment-Resistant Childhood Mood and Anxiety Disorders (2012) (0)
- Chapter 4. Paroxetine (2006) (0)
- Approaches to the treatment of major depressive disorder (2003) (0)
- Effects of interferon (IFN) α on immune, neuroendocrine, and behavioral measures in rhesus monkeys: A potential role for CRF (2006) (0)
- Is the Hypothalamic-Pituitary-Gonadal Axis Dysregulated in Depressed Women? (2001) (0)
- Response to Rubin and Carroll and Van Den Eede et al. (2006) (0)
- Non-sexual interpersonal trauma and PTSD development (2016) (0)
- Poor Maternal Care Influences Response to Psychological Stress in Adults (2004) (0)
- Magnetic Resonance Imaging of the Basal Ganglia in Depression (2019) (0)
- Correction to: The Role of Oxytocin in Early Life Adversity and Later Psychopathology: a Review of Preclinical and Clinical Studies (2019) (0)
- Chapter 9. Bupropion (2006) (0)
- What is an animal model ? (2005) (0)
- Management of Treatment-Resistant Schizophrenia (2012) (0)
- Chapter 29. Sedative-Hypnotics (2006) (0)
- Chapter 32. Treatment of Bipolar Disorder (2006) (0)
- Lifelong outcomes and effects on brain and behavior following childhood maltreatment and early life stress: A primer to inform future research (2022) (0)
- Journal of Clinical Psychiatry: Introduction (2005) (0)
- Management of Treatment-Resistant Depression (2012) (0)
- Treatment-Resistant Generalized Anxiety Disorder (2012) (0)
- An Old Transmitter in a New Millennium (2001) (0)
- Psychoneuroendocrinology of Resilience: An Overview (2018) (0)
- Lithium in the treatment of manic-depressive illness: an update. Proceedings of a meeting. Sea Island, Georgia, USA. May 30-31, 1997. (1998) (0)
- The seminal role of child abuse and neglect in predicting course and treatment response in mood and anxiety disorders: Neurobiology and genetics (2015) (0)
- Chapter 21. Ziprasidone (2006) (0)
- Is Ipsapirone an Effective Antidepressant (1999) (0)
- S.15.05 The HPA axis and the pathophysiology of depression: The role of early adverse experience (1997) (0)
- Chapter 5. Fluvoxamine (2006) (0)
- Neuropeptides and schizophrenia: spinal fluid and brain studies. Introduction. (1985) (0)
- Trafficking of natural killer cells during exposure to psychological stress: Role of the adhesion molecule, L-selectin (2006) (0)
- Cyclic AMP-Dependent Protein - PhosphorylaGon in the Rat Anterior Pituitary (1990) (0)
- Neuropeptides and Affective Disorder (1990) (0)
- Poster #21 BRAIN ACTIVITY DURING MORAL JUDGMENT TASKS IN INDIVIDUALS WITH SCHIZOPHRENIA, THEIR UNAFFECTED SIBLINGS, AND HEALTHY CONTROLS (2012) (0)
- Paroxetine vs. Amitriptyline for Treating Depression in Primary Care (1997) (0)
- More Time for Science and Less Time for Administration? (2016) (0)
- PCP in Monkeys: A Model for Schizophrenia? (1997) (0)
- Neurosciences and neuropsychiatry Editorial overview (1990) (0)
- DNA methylation levels are associated with CRF1 receptor antagonist treatment outcome in women with post-traumatic stress disorder (2018) (0)
- Correction to: Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling (2018) (0)
- Regulation of CRF in BE (2)-M17 and BE (2)-C neuroblastoma cell lines (1995) (0)
- Book Review The War of the Soups and the Sparks: The Discovery of Neurotransmitters and the Dispute over How Nerves Communicate By Elliot S. Valenstein. 237 pp., illustrated. New York, Columbia University Press, 2005. $31. 0-231-13588-2 (2005) (0)
- CSF THYROTROPIN‐RELEASING HORMONE IN PSYCHIATRIC DISORDERS (1992) (0)
- The Long-Term Biological and Clinical Consequences of Child Abuse and Neglect (2021) (0)
- Scary Thoughts: Genetic Polymorphism and Amygdala Response to Fearful Stimuli (2002) (0)
- Transcription factor motifs in anterior insula gene-expression are altered in mood disorder brains (2020) (0)
- Urocortin, the CRF2 receptor and effects of anxiolytic drugs (2000) (0)
- Pharmacological Treatment of Bipolar Depression (2010) (0)
- Treatment-Resistant Bipolar Disorder (2012) (0)
- Self-Assessment in Psychopharmacology (2009) (0)
- Assessing fit of individuals to group-derived structural equation models of resting-state fMRI data (2008) (0)
- Psychological and neurobiological consequences of trauma (1994) (0)
- Blockage of neurotensin-induced antinociception by thyrotropin-releasing hormone in mice (1981) (0)
- The Neuropsychiatry of Limbic and Subcortical Disorders. (1999) (0)
- Lithium Decreases Expression of Gαs mRNA and Protein Levels (2000) (0)
- DRUG DEVELOPMENT OF THE 21ST CENTURY (1999) (0)
- More on the Genetic Susceptibility to Schizophrenia (2002) (0)
- Essentials of Clinical Psychopharmacology, Third Edition (2013) (0)
- Neuropeptide involvement in affective disorders (1990) (0)
- Understanding the Development of Dopamine Neurons (1997) (0)
- Chapter 37. Treatment of Substance-Related Disorders (2006) (0)
- Buprenorphine for Refractory Depression (1995) (0)
- Chapter 20. Risperidone (2006) (0)
- HPA-Axis Activity May Predict Long-Term Treatment Response in Depression (2002) (0)
- Book Forum TEXTBOOKS (2011) (0)
- Antidepressant Prescribing and Suicide (2003) (0)
- Drs. Evans and Nemeroff Reply (1984) (0)
- Chapter 3. Sertraline (2006) (0)
- Epigenome-wide association study to focus on the development of PTSD in traumatized ED patients (2016) (0)
- Adverse Childhood Experiences Increase Risk for Ischemic Heart Disease (2004) (0)
- Structural Racism in Psychiatric Research Careers: Eradicating Barriers to a More Diverse Workforce. (2023) (0)
- 428. Differential effects of alprazolam and lorazepam on plasma cortisol in normal elderly (1996) (0)
- The Council on Research (1995) (0)
- Can personalized medicine mitigate confirmation bias in mental health? (2021) (0)
- The Peace of Mind Prescription: An Authoritative Guide to Finding the Most Effective Treatment for Anxiety and Depression (2004) (0)
- Treatment of severe depression (2000) (0)
- Depression and Heart Disease: Link Is Clear (2006) (0)
- Chapter 25. Carbamazepine and Oxcarbazepine (2006) (0)
- Chapter 15. Classic Antipsychotic Medications (2006) (0)
- Wylie W Vale (2012) (0)
- On Mentoring (1998) (0)
- Can Practice Overcome Language-Based Learning Impairments? (1996) (0)
- The Role of Patient Advocacy in Funding Policy (2000) (0)
- Thyroid Axis Stimulation Tests in Psychiatry (1990) (0)
- HRT Reduces Menopausal Depressed Mood: A Meta-Analysis (1997) (0)
- Developmental Neurobiology and Psychiatry : Challenges and Best Practices for Studies in Children and Adolescents (2005) (0)
- The BE(2)-C cell secretes corticotropin-releasing factor and responds to forskolin (1994) (0)
- Dr. Stowe and Colleagues Reply (2001) (0)
- Social Support Reduces CAD Reactivity (1998) (0)
- Chapter 13. Benzodiazepines (2006) (0)
- Psychoanalysis, Psychodynamic Psychotherapy, and Psychopharmacology (1998) (0)
- Untitled Page (2012) (0)
- Lithium plus TCA for Bipolar Depression (1996) (0)
- P03-383 - Addition of a Selective 5-HT2A/D4 Antagonist Accelerates the Antidepressant Effects of Citalopram (2010) (0)
- MH1: PATTERNS OF USE OF ANTIDEPRESSANT AND CONCOMITANT PSYCHOTROPICS (2000) (0)
- PMH41: PATTERNS OF ANTIDEPRESSANT USE AND CONCOMITANT PSYCHOTHERAPEUTIC AGENTS (2000) (0)
- Alzheimer's Disease and Other Dementias (2005) (0)
- F92. Polygenic Risk Score from Schizophrenia Predicts PTSD and Depression Symptoms After Trauma Exposure (2019) (0)
- Early Life Adversity Modulation of Central Autonomic Network During Emotion Regulation in Borderline Personality Disorder (2020) (0)
- Central Autonomic Network Association With Cardiac Autonomic Sleep-Wake Rhythm in Major Depression and Borderline Personality Disorder (2021) (0)
- Sex Differences in Peri-Traumatic Cortisol and Inflammatory Cytokines Explain Differential Risk for Future PTSD (2020) (0)
- F179. Epigenetic Biomarkers in Women With Posttraumatic Stress Disorder After CRF1 Receptor Antagonist Treatment (2018) (0)
- Early Life Stress and Substance Use Disorders: Underlying Neurobiology and Pathways to Adverse Outcomes (2020) (0)
- Assessing intersubject commonalities and differences with group-derived structural equation models of resting-state fMRI data (2009) (0)
- P716. Consistency in the Prevalence of Self-Reports of Childhood Trauma in Psychiatric Patients: Remarkable Similarity Across Age Groups, Geographic Location, and Treatment Modalities (2022) (0)
- P.183 A neuroimaging study of functional connectivity during an emotion regulation task in major depressive disorder and borderline personality disorder (2019) (0)
- Changes in Functional Connectivity in Remitters to CBT Versus Pharmacotherapy for Depression (2022) (0)
- 525. The Temporal Stability of Cognitive Functioning and Functional Capacity in Women with PTSD (2017) (0)
- 53. Potential Biological Mechanisms of Sex-Dependent Associations Between Peritraumatic Dissociation and Risk for Posttraumatic Stress Disorder (2019) (0)
- List of Contributors (2020) (0)
- The Greatest Kid Ever (1998) (0)
- Childhood Shyness and Adult Amygdalar Responses (2003) (0)
This paper list is powered by the following services:
Other Resources About Charles Nemeroff
What Schools Are Affiliated With Charles Nemeroff?
Charles Nemeroff is affiliated with the following schools:
